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ABSTRACT 
Cell communication governed and coordinated by the WNT family of 
lipoglycoproteins comprises essential physiological processes active throughout the 
life-span of metazoan organisms. In humans, severe diseases and congenital birth 
defects have been directly linked to disturbances in WNT signaling. In line with the 
general scheme of cell signaling transduction, WNT proteins bind and activate cell 
surface receptors in order to relay signaling to intracellular effector molecules which 
subsequently acts to execute changes in cell fates; such as proliferation, differentiation, 
migration and polarization. Thus far, a variety of structurally and functionally different 
proteins are identified as WNT receptors and/or co-receptors.   
The ten members of the Frizzled (FZD) family of seven transmembrane-spanning 
proteins are the preponderant receptors of WNTs and are shown to interact with 
heterotrimeric G proteins and the scaffold phosphoprotein Dishevelled (DVL) to 
activate downstream signaling events. Due to homology in secondary structure, FZDs 
are classified as G protein coupled receptors (GPCRs), but display unconventional 
constitution and signaling properties in respect to e.g. the well-studied Class A 7TMRs. 
This fact generated the generally accepted notion that FZDs in fact are not GPCRs. The 
work presented in this thesis investigates the functional and molecular relationship 
between WNTs, FZDs, G proteins and DVL from a pharmacological point of view.     
The link between WNTs and G proteins has been established mainly through 
epigenetic studies and in genetically manipulated systems. Using the [-35S]GTP 
method to assay G protein activity we demonstrated that WNTs are able to activate G 
proteins of the PTX-sensitive Gi/o family even at endogenous protein levels, thus 
providing evidence that the WNT-G protein connection indeed is not an artifact 
imposed by alterations in protein stochiometry.  
Functional selectivity or biased agonism is a recently established feature of ligand 
activity at GPCRs and have provided important insights into the pharmacological 
aspects of 7TMR signaling. By assessment of downstream WNT signaling events and 
FRAP analysis of FZD6 lateral diffusion we find that WNT isoforms are not 
homologous in signaling pathway activation at a specific receptor or in a defined 
cellular milieu. Thus, our conclusion suggests that WNTs might be able to act as 
endogenous biased agonists at FZDs.  
Even though recent biochemical and bioinformatics data provides the definite 
evidence of FZDs as true GPCRs, signal transduction mechanisms and selectivity in the 
interactions of FZDs, G proteins and DVL are largely unknown. Here we report, using 
a double fluorophores FRAP and cell surface cross-linking approach, that FZD6 protein 
precouples to Gi1 and Gq and that the interaction is sensitive and dynamic to WNT 
stimulation. We also demonstrate that DVL is an essential component in the FZD6-G 
protein precoupled complex. Interestingly, we find that the effect of DVL is 
concentration-dependent: a low as well as a high concentration of DVL destabilizes the 
receptor-G protein complex. Additionally, we establish that a point mutation, R511C, 
in the FZD6 C-terminal region gives rise to autosomal recessive nail dysplasia and 
renders the receptor dysfunctional in G protein precoupling.  
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LIST OF ABBREVIATIONS 
 
7TMR seven transmembrane receptor 
ABC active -catenin 
AGS activator of G protein signaling 
Ala alanine 
APC adenomatous polyposis coli 
aPKC atypical Ca2+-dependent protein kinase 
AR adenosine receptor 
Arg arginine 
AR -adrenergic receptor 
C cystein 
CaMK calmodulin-dependent kinase 
cAMP cyclic adenosine monophosphate 
CBR cannabinoid receptor 
CE convergent extension 
CFP cyan fluorescent protein 
cGMP cyclic guanosine monophosphate  
CK casein kinase 
CRD cystein rich domain 
Cys cystein 
D aspartic acid 
D4476 4-[4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-(2-pyridinyl)-1H-
imidazol-2-yl]benzamide (CK1 inhibitor) 
DEP disheveled/ EGL-10/ Pleckstrin 
DIX disheveled/Axin  
DNA deoxyribonucleic acid 
DVL disheveled 
ECD extracellular domain 
ECL extracellular loop 
e. g. for example (exempli gratia lat.) 
ERK extracellular signal-regulated kinase  
FRAP fluorescence recovery after photobleaching 
FRET Förster resonance energy transfer 
FZD frizzled 
GAP G protein activating protein 
GDP guanosine diphosphate 
GEF guanine nucleotide exchange factor 
GFP green fluorescent protein  
GPCR G protein-coupled receptor 
GSK glycogen synthase kinase 
GTP guanosine triphosphate 
HEK human embryonic kidney  
ICD intracellular domain 
ICL intracellular loop 
i. e.  that is (id est lat.) 
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IP3 inositol triphosphate 
JNK c-Jun N-terminal kinase 
K lysine 
LRP low density lipoprotein receptor-related protein 
MEF mouse embryonic fibroblasts 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
N asparagine 
NECA 1-(6-Amino-9H-purin-9-yl)-1-deoxy-N-ethyl-β-D-
ribofuranuronamide (adenosine receptor agonist) 
NFAT nuclear factor of activated T cells 
PAGE polyacrylamide gel electrophoresis 
PCP planar cell polarity 
PCR polymerase chain reaction 
PDE phosphodiesterase 
PDZ postsynaptic density 95/disc-large/zona occludens-1 
PIP2 phophatidylinositol bis-phosphate 
PI3K phosphatidylinositol 3-kinase 
PKA protein kinase A 
PKC Ca2+-dependent protein kinase 
PLC phospholipase C 
PP protein phosphatase 
Pro proline 
PS-DVL phosphorylated and shifted disheveled 
PTK protein tyrosine kinase 
PTX pertussis toxin (from Bordetella pertussis) 
QPCR quantitative reverse transcriptase polymerase chain reaction 
R arginine 
RGS regulator of G protein signaling 
RNA ribonucleic acid 
ROR receptor tyrosine kinase-like orphan receptor 
RT-PCR reverse transcriptase polymerase chain reaction 
RYK related to receptor tyrosine kinase 
S serine 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SFRP soluble frizzled-related protein  
siRNA small interfering ribonucleic acid 
T threonine 
TCF/LEF T cell-specific transcription factor/lymphoid enhancer factor 
Thr threonine 
TSPAN tetraspanin 
Tyr tyrosine 
Vangl vang-like  
W tryptophan 
WIF WNT inhibitory factor 
WNT wingless/int-1, wingless-type mouse mammary tumor virus 
integration site family 
Y tyrosine 
YFP yellow fluorescent protein  
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1 INTRODUCTION 
 
The WNT signaling system consists of a complex and elaborate cell communication 
network of extracellular agonists and inhibitory molecules, receptors, co-receptors and 
intracellular pathway components. Physiological processes governed by WNTs range 
from embryonic tissue patterning, body axis formation and organogenesis to tissue 
homeostasis and adult stem cell renewal (Clevers, 2006; Nusse, 2012). The importance 
of proper WNT communication has further been appreciated since aberrant WNT 
signaling leads to congenital defects, cancer and neurodegenerative diseases (Holland 
et al., 2013; Logan and Nusse, 2004). The classification of WNTs and related signaling 
components is largely based on amino acid sequence similarity and biochemical 
properties rather than functionality (Logan and Nusse, 2004). However, as more data 
regarding the signaling features of WNTs are gathered, we begin to understand that 
current WNT categorization systems are insufficient (Gordon and Nusse, 2006). In the 
coming section, a general overview of signaling pathways is presented as well as a brief 
introduction to the molecular players involved. As the focus of this thesis is set on 
investigating WNT signaling events at the plasma membrane, the information in the 
subsequent sections will give a more thorough coverage of the central players in 
proximal WNT signaling, namely the seven transmembrane receptors Frizzleds (FZD), 
the intracellular scaffold protein Disheveled (DVL) and heterotrimeric G proteins. In 
the final part pharmacological aspects of WNT/FZD signaling will be commented on.   
 
1.1 GENERAL OVERVIEW OF WNT SIGNALING PATHWAYS 
Cellular communication typically occurs when a signaling molecule at the outside of 
the cell interacts with a transmembranous receiver molecule which has the ability to 
recognize and translate the signal into an intracellular message. The WNT signaling 
system is no exception to this fundamental biochemical process. Over the years, the 
knowledge of the WNT communication system has advanced mainly in the area of 
downstream – and endpoint signaling events as most results have been gained by 
performing epigenetic studies, morphogenic analysis, and measurements of gene 
transcription and second messengers (van Amerongen and Nusse, 2009). The 
information gathered from these studies allowed for the division of WNT-signaling into 
two distinct groups depending on the nature of the downstream outcome of the 
signaling pathway (Kikuchi et al., 2011; Logan and Nusse, 2004; McNeill and 
Woodgett, 2010).       
 
1.1.1 The -catenin-dependent pathway 
The intracellular accumulation and stabilization of the cadherin-binding protein -
catenin was the first identified biomolecular proof of WNT action (Riggleman et al., 
1990) and has since been considered the canonical and most prominent pathway of 
WNT signaling (Shimizu et al., 1997). -catenin is a cytosolic protein which regulates 
cell adhesion and gene transcription, and under normal conditions, in the absence of 
WNTs, the levels of -catenin are kept low by proteasomal degradation (Aberle et al., 
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1997). -catenin is marked for degradation by constantly being phosphorylated and 
ubiquitinated by a multiprotein assembly known as the destruction complex. Key 
components within this complex include the scaffold protein Axin, the adenomatous 
polyposis coli (APC) protein and the enzymes glycogen synthase kinase 3 (GSK3 
and casein kinase 1 (CK1. WNT stimulation by the activation and interaction of 
WNTs with receptors and co-receptors at the plasma membrane leads to the decay of 
the destruction complex, an event which inactivates the phosphorylation of -catenin 
by GSK3 and CK1, and releases Axin (Clevers, 2006; Liu et al., 2002; Logan and 
Nusse, 2004). Active and stabilized -catenin is able to enter into the nucleus where it 
functions as a co-factor to activate the T cell-specific transcription factor/lymphoid 
enhancer factor (TCF/LEF) transcriptional machinery by displacing the transcriptional 
repressor Groucho. The subsequent transcription of target genes, e.g. c-Myc and 
cyclinD1, determines the main role of the WNT/-catenin pathway as a regulator of 
cellular proliferation and differentiation (Hurlstone and Clevers, 2002).  
 
1.1.2 The -catenin-independent pathways 
Research in the WNT field revealed that further effects, besides the stabilization-
catenin, transcription of cell cycle regulating genes and body axis duplication, could be 
mediated by this family of morphogenic proteins. It was found that cellular movement, 
orientation and polarization during embryonic tissue patterning were dependent of 
WNT communication (Heisenberg et al., 2000; Wallingford et al., 2001). Regulation of 
these cellular processes is performed by the two main branches within the -catenin-
independent WNT pathways; namely the WNT/planar cell polarity (PCP) and the 
WNT/Ca2+ pathways (Kikuchi et al., 2011). The PCP pathway was first identified in D. 
melanogaster where it governs movements and polarity of cells within the epithelial 
plane, such as the organization of hairs, bristles and ommatidia (Fanto and McNeill, 
2004). Further, a pathway similar to the D. melanogaster PCP process is involved in 
convergent extension movements of the vertebrate embryo, commonly studied in X. 
laevis and zebrafish (Simons and Mlodzik, 2008). WNT/PCP regulated cellular 
migration and polarity is orchestrated by the downstream activation of small GTP 
binding proteins, Rho and Rac, and related protein kinases, such as c-Jun N-terminal 
kinase  (JNK) and Rho-kinase (Zallen, 2007). The consequent effect leads to 
cytoskeleton rearrangement and coordination (Kikuchi et al., 2011). The second major 
branch of the -catenin-independent pathways is represented by the WNT induced 
release of intracellular Ca2+ (Slusarski et al., 1997b) and activation of related Ca2+ 
responding effectors such as e.g. calmodulin-dependent kinase II (CaMKII) and Ca2+-
dependent protein kinase (PKC), eventually leading to gene transcription via nuclear 
factor of activated T cells (NFAT) (De, 2011; Huelsken and Behrens, 2002; Kohn and 
Moon, 2005; Veeman et al., 2003). Additionally, WNTs have been shown to increase 
Ca2+ by the activation of phosphodiesterases (PDEs) resulting in declining 
concentration of cyclic guanine monophosphate (cGMP) and consequent intracellular 
Ca2+ mobilization (Ahumada et al., 2002; Ma and Wang, 2006). The Ca2+ pathway is 
shown to activate cell migration and to have negative effects on -catenin signaling 
(De, 2011; Kuhl et al., 2001). As the number of studies into WNT/-catenin-
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independent signaling currently is increasing, additional pathways have been identified; 
among them the activation of rap1, atypical protein kinase C (aPKC), mammalian 
target of rapamycin (mTOR),  cyclic adenosine monophosphate (cAMP)/protein kinase 
A (PKA) and phosphatidylinositol 3-kinase (PI3K) (Semenov et al., 2007). The wide 
variety of effects that WNT signaling is capable of driving further highlights the 
necessity of researching WNT communication in a much broader perspective than only 
in developmental processes.  
 
1.2 THE WNT FAMILY AND RELATED EXTRACELLULAR SIGNALING 
MOLECULES 
The name WNT is an acronym derived from the D. melanogaster tissue polarity gene 
wingless and the mammalian mammary proto-oncogene int-1 (Nusse et al., 1991). This 
protein family, which was defined in the 1980s by the discovery that wingless and Int-1 
are orthologs (Rijsewijk et al., 1987), is highly conserved throughout evolution and the 
mammalian genome harbors 19 different WNT isoforms, named as follows: WNT-1, -
2, -3, -3A, -4, -5A, -5B, -6, -7A, -7B, -8A, -8B, -9A, -9B, -10A, -10B, -11, -16 (Nusse, 
1997-2013). WNTs act as morphogens and signaling occurs both at short distances; i.e. 
WNTs can act in autocrine and paracrine manners, as well as being able to mediate 
communication over longer distances (Port and Basler, 2010). The general biochemical 
structure of WNTs contains an N-terminal signal sequence of approximately 20 amino 
acids necessary for proper secretion but which, in some cases, also is cleaved off to 
regulate WNT activity and function (Willert and Nusse, 2012). All WNT members 
contains high numbers of cysteine resides and even though analysis of primary amino 
acid structure predicts hydrophilic properties, WNTs typically binds tightly to 
extracellular matrix (ECM) structures and exhibit hydrophobic features (Clevers, 2006; 
Lorenowicz and Korswagen, 2009). These properties make WNT proteins particularly 
hard to isolate and purify and are the results of i) acetylations: palmitations at 
conserved cysteines and palmitoylations at serines, and ii) multiple and a highly 
variable number of N-linked glycosylations (Kurayoshi et al., 2007; Willert et al., 
2003). These series of posttranslational modifications are important for secretion, 
activity and transportation; especially acetylation seems indispensable for WNT 
activity (Schulte et al., 2005; Willert et al., 2003). Owing their cysteine-rich and 
hydrophobic character, WNTs may be expected to show ordered secondary and tertiary 
structures. Indeed, in a recent study by Janda and colleagues (Janda et al., 2012), the 
crystal structure of X. laevis WNT-8 revealed a unique 3-dimentional structure, held 
together by disulfide bridges between 22 conserved cysteines, and divided into two 
distinct domains: an N-terminal -helical-containing cluster (“the thumb”) and a C-
terminal dual -sheet part (“the  index finger”). A linker region of nonconserved 
residues stretches between the two domains (“the palm”) and current results indicate 
that this region probably does not participate in receptor binding (Janda et al., 2012; 
Willert and Nusse, 2012). Possibly, this flexible part of WNTs might be subjected to 
genetic modification, e.g. potential site for the introduction of internal tags. 
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WNTs (and WNT signaling-related components) are commonly categorized according 
to their activity in either -catenin-dependent or –independent pathways (McNeill and 
Woodgett, 2010).  Assessment of -catenin dependent pathway is fairly robust, and a 
battery of methods is available; such as the ability of the WNT to induce X. laevis 
embryo body  axis duplication,  transformation of C57MG cells, the phosphorylation of 
upstream effectors, activation of luciferase LCF/TCF-driven reporter gene and of 
course the stabilization of -catenin itself. The analyses of -catenin independent 
pathways, on the other hand, are still suffering from the lack of robust readout assays 
(van Amerongen, 2012). According to the current understanding, which is limited to 
only a subset of the different WNT-isoforms, WNTs that are considered -catenin-
dependent are: WNT-1, WNT-3, WNT-3A, WNT-7A, WNT-8A and WNT-8B, and 
WNTs signaling through -catenin-independent pathways are: WNT-2, WNT-4, WNT-
5A, WNT-5B, WNT-6, WNT-7B and WNT-11 (Chien et al., 2009; Kikuchi et al., 
2007; McNeill and Woodgett, 2010). However, depending on the cellular context and 
the readout assay used, WNT-isoform specific effects, with regard to pathway outcome, 
can often be shown to overlap. Thus, classical -catenin-signaling WNTs can in some 
situations perform -catenin-independent signaling and vice versa (Holmen et al., 2002; 
Kishida et al., 2004; Slusarski et al., 1997a; van Amerongen et al., 2012).   
 
Signaling feed-back loops are important in regulation of WNT communication. Positive 
and negative modification is achieved not only by combinations of different WNT-
isoforms, but also by unrelated extracellular molecules (Cruciat and Niehrs, 2013; 
Kawano and Kypta, 2003). Some of these are true activators of WNT-signaling, such as 
Norrin which binds and activates FZD4 to induce -catenin stabilization (Huang and 
Klein, 2004; Xu et al., 2004). R-spondins are a group of proteins which, by acting 
through LGRs, sensitizes cells to WNT responses (Carmon et al., 2011; de Lau et al., 
2012; Glinka et al., 2011). Dickkopfs (DKKs), Wise/Sclrostin and WNT inhibitory 
factors (WIFs) act to antagonize WNT signaling, often in an autocrine manner, and are 
shown to be upregulated in response to activation of some WNT pathways (Cruciat and 
Niehrs, 2013; MacDonald et al., 2009; Niehrs, 2006). Soluble Frizzled-related proteins 
(SFRPs) are also seen as inhibitors of WNT signaling. This group of extracellular 
proteins contains a FZD-like cysteine rich domain (CRD) motif which is used to bind 
and sequester WNTs thus competing with the considered FZD orthosteric binding site 
(Hsieh et al., 1999a; Jones and Jomary, 2002).      
 
1.3 WNT RECEPTORS 
In line with the principal organization of cellular communication WNTs exert their 
action through binding to cell surface transmembrane receptor proteins. However, 
WNTs are quite unique in the sense that they are able to activate a number of receptors 
differing greatly in structure and signaling mechanism (Kikuchi et al., 2007). With the 
general advances in molecular biology and the development of improved purification 
protocols of WNTs, the number of identified WNT receptors has increased, and the 
picture is getting more and more complex and complicated. Today, more than 15 
different receptors and co-receptors are known to be engaged in WNT signaling 
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(Niehrs, 2012). The preponderance of WNT signaling communication occurs via the 
activation of the Frizzleds and therefore, this family of 7TM spanning proteins is 
considered being the chief WNT receptors (Schulte, 2010).  
 
1.3.1 Frizzleds 
FZDs were first described in 1989 by the investigation of PCP signaling genes in the D. 
melanogaster frizzled mutant fly (Vinson et al., 1989). However, FZDs were not 
recognized as bona fide WNT receptors until the late 1990s (Bhanot et al., 1996). 
Today, it is common knowledge in the WNT field, that FZDs are crucial signal 
transducers in most WNT communication pathways.     
 
1.3.1.1 FZD structure and classification 
Owing their seven transmembrane helices spanning (7TM) structure, all the members 
of the Frizzled family (FZD1-10) as well as the Hedgehog pathway receptor Smoothened 
(SMO) are classified as G protein coupled receptors (GPCRs) in the Class Frizzled (or 
Class F) (Fredriksson et al., 2003; Lagerstrom and Schioth, 2008; Schulte, 2010). Class 
Frizzled receptors share high similarity in amino acid sequence, structure and 
conserved motifs; including i) the extracellular domain (ECD) with the CRD structure 
and the ECD linker domain, ii) the 7TM domains (common for all GPCRs), and iii) the 
intracellular domain (ICD) with a PDZ-ligand motif, KTxxxW (x = any amino acid), 
which in SMO contains an Ala between the Lys and the Thr residues (Wang et al., 
2013). Based on sequence homology, Class F receptors are grouped into four distinct 
clusters: FZD1, 2, 7; FZD3, 6, SMO; FZD4, 9, 10; FZD5, 8 (Schulte, 2010). With the recently 
solved crystal structure of SMO bound to an antitumor agent (LY2940680) at hand 
(Wang et al., 2013), the structure of FZDs can be discussed more in detail. In the 
following subsections, the findings regarding the SMO protein structure will serve as a 
template for deduction of FZD molecular features.    
 
1.3.1.1.1 The Class Frizzled ECD 
The length of the ECD varies among the Class F receptors but all contain a short N-
terminal signal sequence necessary for posttranslational trafficking and insertion in the 
plasma membrane. The signal sequence is followed by a number of Cys residues (10 in 
FZDs and 9 in SMO) which forms 5 (FZD) and 4 (SMO) disulfide bonds thus 
stabilizing a specialized α-helical-rich tertiary structure of approximately 120 amino 
acids, named the CRD (Dann et al., 2001; Schulte, 2010). In the case of SMO, the 
function of the CRD is unknown, but in FZDs the CRD constitutes the proposed 
orthosteric site for binding of ligands, i.e. WNTs, Norrin and SFRPs (Xu and Nusse, 
1998). High affinity binding of a Kd of 1-10nM exist between WNTs (Carmon and 
Loose, 2010; Hsieh et al., 1999b; Rulifson et al., 2000) and the FZD-CRD and the 
recently described mouse FZD8-CRD/X. laevis WNT-8 interaction complex reveals 
further hints of how WNTs engage in receptor binding and recognition (Janda et al., 
2012). It was shown that XWNT-8 forms a pinching grip, created by hydrophobic 
contacts, which arches around the CRD with the N-terminal “thumb” domain and the 
C-terminal “index finger” part interacting with sites located on opposite sides of the 
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CRD (Janda et al., 2012). However, the role of the CRD in receptor conformation 
modulation and activation remains to be further investigated since WNT signaling still 
can be employed at FZDs lacking the CRD (Chen et al., 2004; Povelones and Nusse, 
2005). The FZD-CRD also contains Asn residues predicted to be N-glycosylated 
(Wang et al., 2006), a posttranslational modification probably involved in proper 
signaling, maturation and compartmentalization of FZDs (Schulte, 2010; Yamamoto et 
al., 2005). The CRD is connected to the ECD linker domain which contains further 
conserved Cys residues forming disulfide bonds and intricate tertiary structures in 
contact with the extracellular loop regions (ECLs) (Wang et al., 2013).  
 
1.3.1.1.2 The Class Frizzled 7TM core 
A unique feature of class F receptors compared to the well-studied class A GPCRs are 
the long ECLs. In SMO the three ECLs forms complex structures by Cys-Cys disulfide 
bonds, hydrophobic forces and non-covalent interactions with the ECD linker domain 
(Wang et al., 2013). This extracellular ordered structure is shown to be necessary for 
proper regulation of SMO activity. Mutation of the conserved Cys residues in 
extracellular regions disrupts the inactive conformation of SMO and yields a 
hyperactive receptor (Carroll et al., 2012). The ECL2 seems especially important in 
regulation of receptor activity, since disruption of the Cys in this region renders SMO 
inactive (Lagerstrom and Schioth, 2008) and heterozygous mutation of the ECL2 Cys 
in the D. melanogater fz gene causes partial loss of function (Povelones et al., 2005). In 
the extracellular part of SMO the only secondary structure found to be shared with class 
A receptors is the -hairpin of ECL2, but still there are discrepancies between SMO 
and the class A in the function of this structure (Wang et al., 2013). Even though the 
primary sequences of the ECL1-3 are highly conserved in class F receptors there are 
differences when it comes to the mature protein structure: e.g. FZD4, which has a very 
short ECL3, cannot form a disulfide bond in the loop3 region, and the FZD3 and 6 
harbors a predicted N-glycosylation site in the ECL2 (MacDonald and He, 2012; Wang 
et al., 2013). These differences might contribute to the determination of ligand 
selectivity (Schulte, 2010).  The transmembrane segments of class F are made up of 
seven -helices (I-VII) – the hallmark structure of the GPCR superfamily (Pierce et al., 
2002). On the other hand, the class F receptors are lacking the class A-conserved motifs 
which are critical for the interaction with heterotrimeric G proteins. Such are the DRY-
motif in helix III and the NPxxY-region in helix VII, both situated at the border to the 
intracellular surface (Katritch et al., 2013; Rovati et al., 2007; Wess, 1998). The fact 
that FZDs are lacking these essential motifs provides one of the main arguments against 
the GPCR-thesis of FZDs. Interestingly, class F receptors contain a high number of 
tryptophans in the intracellular ends of helices III, IV and VII and these are shown to be 
involved in receptor activation (Xie et al., 1998). Moreover, in the case of helix VII, the 
Trp residue aligns with the NPxxY-motif of class A receptors (Wang et al., 2013).  
 
1.3.1.1.3 The Class Frizzled ICD         
Given the 7TM spanning structure, the GPCRs contain an intracellular region of 3 
loops and a C-terminal tail. These structures provide an interaction platform for 
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intracellular binding partners and are subjected to various posttranslational 
modifications, e.g. phosphorylation, nitrosylation, hydroxylation and ubiquitination, 
determining receptor signaling dynamics and compartmentalization (DeWire et al., 
2007; MacDonald and He, 2012; Xie et al., 2009; Yanfeng et al., 2006). The class F 
ICD tail is variable in length and contains the highly conserved PZD-ligand domain: 
KTxxxW (KATxxxW in SMO), responsible for binding to the PDZ domain of DVL 
(Gao and Chen, 2010; Umbhauer et al., 2000; Wallingford and Habas, 2005). Clues 
obtained from the SMO structure might further implicate a role of the PDZ-ligand 
domain in G protein coupling. The SMO KATxxxW domain stabilizes the formation 
and integrity of the short -helix VIII, a structure positioned perpendicular to helix VII 
and additionally is found in bona fide GPCRs (Rasmussen et al., 2007; Wang et al., 
2013; Wess et al., 2008). The formation and stabilization of helix VIII requires a 
number of C-terminal Cys residues and is possible in most, but not all FZDs (i.e. cluster 
1 FZD1, 2, 7) (Schulte, 2010). Moreover, charged amino acids at the beginning and the 
end of the ICL3 exists in class A and class F receptors alike and these residues are 
shown to be important in G protein coupling . Interestingly, these regions in ICL3 are 
further implicated in binding to the C-terminal regions of DVL, thus establishing a 
situation where DVL- and G protein interaction sites essentially are superimposable 
(Schulte, 2010; Tauriello et al., 2012). In the extreme C-terminal part FZDs hold an 
additional PDZ-ligand domain, however not involved in DVL-PDZ interaction. This 
domain has been shown to interact with class I PDZ-domains of several proteins of 
currently unknown function, and is experimentally confirmed in all FZDs except FZD6, 
9 and 10 (Hering and Sheng, 2002; MacDonald and He, 2012; Schulte, 2010).  
 
1.3.1.2 FZD signal transduction 
As mentioned previously, the CRD of FZDs is viewed as the primary ligand interaction 
site. However, it is a consequence of the fact that no other data regarding FZD-ligand 
binding is available. Most FZD-WNT binding studies are performed by isolating the 
CRD of different FZDs and thereafter measuring WNT-CRD binding affinities 
(Carmon and Loose, 2010; Koval and Katanaev, 2012; Schulte and Bryja, 2007). 
Current opinions in the field of GPCR signaling suggest that several ligand interactions 
sites exist at GPCRs, capable of stabilizing different active (and inactive) 
conformations and thus able to direct signaling into divergent pathways (Katritch et al., 
2013; Kenakin, 2011; Kenakin and Christopoulos, 2013). This notion, in combination 
with the fact that the CRD, in some cases, seems dispensable for WNT/FZD signaling 
points to the existence of further sites important for ligand binding. Since WNT binding 
studies are further hampered by the difficulty in obtaining purified WNT proteins, 
WNT-FZD binding pairs are commonly deduced by investigating intracellular 
signaling fates. Based on this approach and WNT-CRD binding assays, some specific 
WNT-FZD interaction pairs have been identified. For example WNT-3A was shown to 
interact with FZD1, 3, 4, 5 and 8 , WNT-5A could mediate signaling via FZD2, 4, 5 and 7, 
WNT-7A was shown to bind FZD5 and 10, and WNT-11 interacted with FZD7(Carmon 
and Loose, 2010; Katanaev and Buestorf, 2009; Kikuchi et al., 2011). The capacity of 
the FZD-CRD to form dimers with itself and other CRD-containing proteins further 
suggests a role of the CRD in coreceptor binding, FZD homo- and heterodimerization 
 16 
as well as interaction with SFRPs (Schulte, 2010; Schulte and Bryja, 2007). In 
conclusion, not much is known about the mechanisms of how FZD signal transduction 
is activated at the extracellular surface.  
 
FZDs, like other GPCRs, do not harbor any intrinsic enzymatic activity and are thus 
reliant on intercellular signaling molecules to mediate further cell communication 
(Dale, 1998). The ICL1-3 and the ICD are the sites of interaction of FZDs with 
intracellular regulatory factors and the ICD region is also the least conserved parts 
among FZDs (Kikuchi et al., 2007). As mentioned earlier, the FZD molecular structure 
provides profound evidence for the interactions with heterotrimeric G proteins and the 
central WNT-signal mediator DVL at overlapping regions in the ICL3 and helix VIII 
(Koval et al., 2011; Tauriello et al., 2012; Wang et al., 2013). Using loss- and gain of 
function experiments G proteins can readily be linked to developmental processes 
(Malbon, 2005). However, the direct link between FZDs and G proteins has proven 
difficult to establish. Adrenergic-FZD chimera receptors provided evidence that the 
intracellular region of FZD behaves similar to conventional GPCRs with regard to 
ligand affinity shift (Ahumada et al., 2002; Malbon, 2004). A recent study using 
WNT8-FZD fusion proteins expressed in yeast showed that FZDs act through G 
proteins to activate yeast MAPK pathway (Nichols et al., 2013), and in vitro direct G 
protein activation of reconstituted bacterially expressed FZD1, 6 and 7 was shown after 
stimulation with WNT-3A, -5A, -5B and -7A (Katanaev and Buestorf, 2009). WNT 
stimulation causes hyperphosphorylation, redistribution and recruitment of cytosolic 
DVL to FZDs at the plasma membrane, an event which can be studied by immuno-
based methods (Schulte and Bryja, 2007). Interestingly, the overexpression of FZDs 
yields a similar result which suggests that DVL can interact with FZDs in the absence 
of WNT activation (Frojmark et al., 2011; Takada et al., 2005). The KTxxxW domain 
of FZDs is the conventional site of interaction with DVL. However, recent results from 
combinatorial peptide scanning of FZD5 and DVL1 interaction sites revealed two 
regions (motif I and II) in the ICL3, conserved in all FZDs except FZD3 and FZD6, 
which provides strong binding to DVL1 C-terminal parts. The interaction of this region 
of DVL1 with FZD5 motif II in ICL3 was found crucial for activation of downstream 
WNT/-catenin signaling (Tauriello et al., 2012). Moreover, DVL have been shown to 
recruit aPKC and CK1/2 to FZDs, a mechanism possibly leading to phosphorylation of 
conserved Ser/Thr and Tyr residues in the FZD ICLs and ICD (Malbon and Wang, 
2006).  
 
Current models of GPCR signaling describe the 7TM receptor protein as a dynamic 
entity, constantly switching between different states of conformational and functional 
arrangements (Canals et al., 2011). Apart from the obvious states of fully active and 
inactive conformations, the set of possible molecular arrangements includes a wide 
range of intermediate states with different degrees of activity (Flordellis, 2012; 
Venkatakrishnan et al., 2013). The stabilization, and consequently the equilibrium of 
these states are affected, not only by extracellular ligands, but also by ions, lipids, 
cholesterols, intracellular binding partners and molecular modifications of the GPCR, 
e.g. phosphorylation (Katritch et al., 2013). The preassembly of a GPCR-effector 
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molecule complex can establish a specific conformation favorable for the interaction 
with a specific extracellular ligand, which upon binding will stabilize a new 
conformational state of the receptor (Audet and Bouvier, 2012). This behavior of 
GPCRs is made possible by allosteric binding sites at the receptor proteins, both at 
intracellular and extracellular regions, and is a phenomenon described in the ternary 
complex model of GPCR signaling (De Lean et al., 1980). Moreover, G protein-
mediated allostery provided the first evidence of G protein signaling at 7TM receptors 
(Lefkowitz, 2007). Using purified receptors and G proteins it was found that when 
depriving the system of GTP the GDP-bound G protein interacted with the GPCR and 
established a conformational state of high ligand affinity. The addition of GTP caused 
dissociation of the G protein from the 7TM protein and shifted the affinity for the 
ligand to a lower state (De Lean et al., 1980).  In this way, allosteric modulation of 
FZDs by the interaction with G proteins and other intracellular regulatory components 
could modify selectivity in WNT binding.   
   
1.3.1.3 FZD molecular dynamics 
Protein dimerization is a frequently occurring phenomenon in nature, and has been 
suggested to facilitate proper maturation, localization, enzymatic activity and signal 
transduction of proteins (Lohse, 2010; Terrillon and Bouvier, 2004). Today there is a 
growing body of evidence arguing for the concepts of homo-and heterodimerization of 
7TM receptors at least among the Class A receptors, the Class B secretin receptors and 
the Class C metabotropic glutamate receptors (Milligan, 2009; Milligan et al., 2006). In 
the case of FZDs it was found that FZD dimerization via the FZD-CRD was sufficient 
to activate WNT/-catenin signaling (Carron et al., 2003) and the crystal structure of 
FZD8-CRD demonstrated a tendency to form homodimers (Dann et al., 2001). 
Interestingly, FZD-FZD interaction of human FZD4 was shown to occur via regions in 
the 7TM helices and thus, did not require the CRD for dimerization (Kaykas et al., 
2004). However, disulfide bonds in the ECD and ECLs were shown to be important for 
dimerization since the use of reducing agents prevented FZD-FZD complex formation 
(Carron et al., 2003; Kaykas et al., 2004). The process of FZD oligomerization has in 
some cases also been found indispensable for proper signal transduction, receptor 
maturation and cell surface localization (Carron et al., 2003). Further, the crystallization 
of SMO revealed a dimer complex in the structure supporting the notion of 
dimerization among Class F receptors (Wang et al., 2013). However, the dimerization 
of receptors in a purified crystal structure is a common theme and can sometimes be 
regarded as an artificial event created by the crystallization procedure and not 
necessarily connected to any physiological relevance (Congreve and Marshall, 2010). 
The process of receptor homo- and heterodimerization can affect the ability to bind and 
recognize ligands and consequently to direct signaling into different pathways 
(Milligan et al., 2006). For example, WNT/-catenin dependent signaling in X. laevis 
was found mediated via FZD3 dimers (Carron et al., 2003). Forced dimerization of 
FZD7 resulted in the WNT/-catenin pathway while monomers of FZD7 transduced 
WNT/-catenin independent signaling (Carron et al., 2003). The concept of 
dimerization among Class F receptors is further complicated by the possibility of 
heteromeric complexes. Between all 10 FZD isoforms and SMO, the plausible 
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combinations are many. Moreover, the possibility of heterodimerization between Class 
F 7TM proteins and receptors of the other GPCR classes cannot be excluded (Koval et 
al., 2011; Parker et al., 2011; Schulte, 2010).  
 
Internalization of GPCRs is a common mechanism to shut down and desensitize 
signaling and occurs both in a constitutive manner and in direct response to agonist 
stimulation (Freedman and Lefkowitz, 1996). Removing the receptor from the site of 
action and making them inaccessible to ligand binding will effectively inhibit further 
signal transduction. Once internalized receptors can either be recycled back to the 
plasma membrane or be subjected to lysosomal degradation (Ferguson, 2001).  
Internalization of 7TM receptors occurs via either caveolae- or clathrin-mediated 
processes (Liu and Shapiro, 2003). The molecular composition of the compartment in 
which the receptor resides determines the choice of internalization pathway. Caveolae-
internalization and subsequent caveosome formation happens in so called lipid rafts, 
regions rich in cholesterol, sphingolipids and the transmembrane caveolin protein 
(Nichols, 2003). In contrast to caveolae-mediated internalization, which remains poorly 
understood, the clathrin-mediated process is well-investigated and results in formation 
of early endosomes. Plasma membrane invaginations coated with intracellular clathrin 
assemblies (clathrin-coated pits) are pinched off by the aid of the GTPase activity of 
dynamin to generate an endosomal GPCR-containing structure (McMahon and 
Boucrot, 2011). Several FZDs (FZD1, 2, 4, 5 and 7) are shown to be subjected to WNT-5A 
or -11-induced clathrin-mediated endocytosis (Chen et al., 2009; Chen et al., 2003; 
Kurayoshi et al., 2007; Yu et al., 2007) and stimulation by WNT-3A was found to 
induce caveolae-mediated internalization of a FZD5/LRP6 receptor complex 
(Yamamoto et al., 2006). Current opinions also suggest a positive role for receptor 
internalization in the processes of cell communication. Establishment of WNT 
gradients in D. melanogaster wing discs requires endocytosis of WNTs with related 
receptors and signaling components (Marois et al., 2006), and blocking caveolae-
mediated endosome formation inhibits WNT-3A-activation of -catenin dependent 
signaling (Sakane et al., 2010; Yamamoto et al., 2006). Since inhibition of the clathrin-
mediated internalization process mainly is connected to impaired WNT/PCP signaling, 
the current understanding dictates a general division of WNT/-catenin dependent 
signaling being associated with caveolae-mediated internalization and -catenin 
independent pathways connected to clathrin-mediated endocytosis (Kikuchi et al., 
2011, 2012).  
 
1.3.2 Additional WNT receptors 
As mentioned earlier, apart from FZDs, WNTs are shown to engage a variety of 
structurally unrelated receptors and co-receptors and some will briefly be presented 
here, i.e. Low-density lipoprotein receptor-related protein 5/6 (LRP5/6), Receptor 
tyrosine kinase-like orphan receptor 1/2 (ROR1/2), Related to receptor tyrosine kinase 
(RYK), protein tyrosine kinase (PTK7), Tetraspanin (TSPAN) and Vang-like (Vangl). 
In many cases both -catenin-dependent and -independent WNT signaling requires 
these receptors and co-receptors to work in concert (primarily with FZDs) and the 
different possible combinations are indeed numerous (Kikuchi et al., 2011). Some 
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combinations, however, favor some WNT pathways more than others and such is e.g. 
the case of LRP5/6.  
 
1.3.2.1 LRP5/6 
These type I single transmembrane spanning LDL receptor family proteins are 
important components in the WNT-FZD-mediated stabilization of -catenin. The 
LRP5/6 have a large ECD which contains multiple binding sites for WNTs; e.g. WNT-
3A and WNT-9B are shown to interact with different domains and in tandem (Bourhis 
et al., 2010). The binding of WNTs to LRP5/6 establishes a WNT-FZD-LRP 
signalosome responsible for mediating -catenin-dependent signaling. The ECD of 
LRP5/6 also functions in an antagonistic manner to negatively regulate WNT signaling 
by binding DKKs. Within a few minutes after WNT activation of FZD, the short 
intracellular domain of LRP5/6 is phosphorylated at serines and threonines surrounding 
five PPSPXS repeats characteristic for these receptors (Wolf et al., 2008). The 
phosphorylation of LRP5/6 provides a binding platform for Axin (the scaffold protein 
of the destruction complex), which upon LRP5/6-mediated recruitment to the 
plasmamembrane causes the destruction complex to dissociate and the degradation 
process of -catenin ceases (Angers and Moon, 2009).  
 
1.3.2.2 ROR1/2, RYK and PTK7 
The ROR1/2, RYK and PTK7 proteins belong to the receptor tyrosine kinase family 
but are atypical in the sense their enzymatic activity either is inactive or is dispensable 
for signal transduction (Green et al., 2008). These receptors are implicated to function 
in both -catenin-dependent and –independent branches, but appears to be 
physiologically relevant mainly in CE cellular movements during embryonic 
development (Grumolato et al., 2010). ROR1/2 harbors an extracellular CRD capable 
of binding WNTs and can convey signaling independently of FZDs. Especially WNT-
5A is shown play a prominent role in signal transduction via ROR1/2 resulting in 
migration and cell polarization (Minami et al., 2010). Whilst WNT-5A/-catenin-
independent ROR signaling seems to require the catalytic Tyr kinase domain (Mikels et 
al., 2009), -catenin signaling by WNT-3A do not, but instead employs ROR2 as a co-
receptor to FZD (Li et al., 2008). WNT-5A activation of ROR2 can also inhibit and 
counteract WNT-3A-induced -catenin stabilization (Mikels et al., 2009; Mikels and 
Nusse, 2006).  
 
The intracellular Tyr kinase domain of the RYK protein is catalytically inactive and 
thus, this receptor functions mainly as a co-receptor. In collaboration with FZD7 and 
WNT-11 it acts to promote CE movements (Kim et al., 2008) and when combined with 
FZD8 and WNT-1 it activates -catenin signaling (Lu et al., 2004a).  Physiologically, 
RYK is crucial for axon guidance and neurite outgrowth (Lu et al., 2004a).  Like RYK, 
PTK7 has an inactive Tyr kinase domain and is viewed purely as a co-receptor (Lu et 
al., 2004b). Since PTK7 deletion mutants exhibit WNT-5A/PCP pathway-related 
defects, WNT-5A is so far thought to activate PTK7 signaling (Shnitsar and Borchers, 
2008) but currently not much is known about the signaling features of these proteins.  
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1.3.2.3 Tetraspanins and Vangl1/2 
The tetraspanin protein TSPAN12 is shown to participate in WNT signaling as a 
coreceptor by facilitating FZD4 oligomerization during Norrin-induced stablilzation of 
-catenin. In this case, tetraspanins are not involved in WNT/-catenin signaling 
(Junge et al., 2009). Like the tetraspanins, the Vangl1/2 proteins are four-pass 
transmembrane proteins. Vangl proteins are implicated as key components of the PCP 
pathway and CE movements during neural tube closure (Lei et al., 2010; Wu and 
Mlodzik, 2009). Signaling mediated by WNT-5A was shown to activate CE pathway 
via either a Vangl2-ROR2 complex (Gao et al., 2011) or a FZD3-Vangl2 composite 
(Shafer et al., 2011). 
 
1.4 INTRACELLULAR EFFECTORS OF THE WNT SIGNALING 
NETWORK 
The next step in the scheme of cellular signal transduction is the activation of 
intracellular effector proteins and in the case of WNT signaling these components 
include both specialized WNT communication molecules, as well as general and 
common cell signaling factors. Utilization of common downstream signaling molecules 
enables the WNT communication network to crosstalk with other cellular signaling 
pathways (Dalton, 2013; Jin and Esteva, 2008; Kikuchi et al., 2011). WNT signaling 
has e.g. been linked to autophagy via convergence with mTOR signaling, to modulate 
immune responses, and directly interact with synaptic signaling, e.g. cholinergic- and 
glutamatergic neurotransmission (Halleskog et al., 2012; Halleskog et al., 2011; 
Inestrosa and Arenas, 2010; Semenov et al., 2007). The FZD associated signaling 
effectors, i.e. DVL and heterotrimeric G proteins, provides a good example of the use 
of specialized versus general cell signaling components in the WNT communication 
system.  
 
1.4.1 Dishevelled – the specialized effector and conventional WNT/FZD-
signaling player 
Dishevelled was first identified in D. melanogaster mutants displaying disruptions in 
hair and bristle polarity (Fahmy and Fahmy, 1959), and was later linked directly to 
WNT/-catenin signaling and WNT/PCP pathway by its key functions in coordinating 
D. melanogaster embryo segment polarity and development of wing, legs and abdomen 
(Wallingford and Habas, 2005). Since then, DVL is found to function as a scaffold and 
molecular switch between -catenin-dependent and independent pathways and is 
appreciated as the central mediator of most, if not all, WNT-signaling events (Axelrod 
et al., 1998; Boutros and Mlodzik, 1999; Malbon and Wang, 2006; Wharton, 2003). 
The scaffold function of DVL allows for the binding and coordination of several 
positive- and negative WNT-signaling components, such as Axin, WNT-signaling 
connected kinases and ubiquitin ligases, and G-subunits (Gao and Chen, 2010).  The 
mammalian genome encodes three isoforms of DVL proteins, DVL1-3, with functional 
redundancy (Lee et al., 2008). However, the native abundance of the different DVL 
   21 
isoforms differs: in HEK293 and P19 cell lines, DVL2 constitutes >80% of the total 
DVL pool and DVL1 and -3, combined, makes up the remaining ~20% (Lee et al., 
2008; Ma et al., 2010). The ~90kDa sized DVL protein structure harbors three distinct 
and functionally conserved domains: the N-terminal DIX (Dishevelled/axin), the mid-
region PDZ (Post-synaptic density-95/Discs-large and Zonula occludens-1), and the C-
terminal DEP (Dishevelled/Egl-10/Pleckstrin) domain (Wallingford and Habas, 2005). 
Two additionally conserved regions of DVL proteins constitute the basic and Ser/Thr-
rich region and the Pro-rich region which could provide sites for phosphorylation or 
protein binding. Indeed, the Pro-rich region contains a SH3 protein binding motif (Gao 
and Chen, 2010). Divergence in sequence homology between the different DVL 
isoforms is most profound in C-terminal parts of DVLs (Ma et al., 2010).  
 
1.4.1.1 The DIX domain 
The DVL-DIX domain has the capacity to mediate polymerization of DVL molecules 
and hetero-oligomerization with Axin via interaction with the Axin-DIX domain, albeit 
the assistance of additional sequences flanking the DVL-DIX is needed (Gao and Chen, 
2010; Wharton, 2003). DIX-mediated multimerization was found crucial for WNT/-
catenin signaling and mutations in the DIX domain have severe effects on WNT-
signaling (Schwarz-Romond et al., 2007a). However, overexpression of isolated DIX 
domains, as well as DEP, was found sufficient for blocking WNT-3A/-catenin 
signaling (Pan et al., 2004). Conversely, deletion of DVL3-DIX was shown to inhibit 
WNT-5A/Ca2+/NFAT pathway, an interesting result with regard to the fact that the 
majority of current data links the DIX domain to WNT/-catenin pathway (Ma et al., 
2010). On the other hand, DIX domain deletion mutation in X. laevis resulted in 
elevated Ca2+ signaling with active CamKII and membrane-recruited PKC (Sheldahl et 
al., 2003). Additionally, DVL is shown interact with actin stress fibers and vesicles 
through the DIX domain (Capelluto et al., 2002).  
 
1.4.1.2 The PDZ domain 
The PDZ domain of DVL serves as the docking site for the FZD KTxxxW PDZ-ligand 
domain and for the interaction with the C-terminal tail of RYK and PTK7 (Wong et al., 
2003). Beyond its role in receptor binding the PDZ domain mediates the interaction 
with a vast array of intracellular signaling components (Wallingford &Habas, 
2005)(Gao and Chen, 2010) and is also necessary for the binding of DVL to Axin. 
Owing its diversity in protein interaction, the PDZ domain has been proposed to serve 
as the conductor of the WNT-pathway switching function of DVL (Wallingford and 
Habas, 2005). DVL further binds directly to CK1//2 via the PDZ and 
phosphorylation sites within the PDZ and DEP domains are thought to be recognized 
by CK1, CK2 and PAR-1b(Bernatik et al., 2011; Gao and Chen, 2010)(Bryja et al., 
2007b; Elbert et al., 2006). The PDZ was also found to be required for microtubule 
stabilization by inhibition of GSK3-mediated phosphorylation of microtubule-
associated proteins (Krylova et al., 2000). DVL has also been shown to bind directly to 
the parathyroid hormone type 1 receptor (PTH1R) to regulate bone growth in a non-
WNT-mediated -catenin-dependent signaling pathway. The DVL-PTH1R interaction 
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occurred at a C-terminal tail sequence, KSxxxW, which highly resembles the FZD PDZ 
ligand domain (Romero et al., 2010). These results suggest that DVL might not be 
confined only to WNT/FZD signaling but could be employed as a more general 
coordinator of cell communication pathways.    
 
1.4.1.3 The DEP domain 
Recent data provided strong evidence for the essential functions of the DEP domain 
and the C-terminal region in interaction with motifs I and II in the FZD5-ICL3, thus 
explaining previous observations of the KTxxxW-PDZ domain binding being 
dispensable for FZD-DVL association (Tauriello et al., 2012). A polybasic stretch of 
amino acids in the DEP domain further supports the anchoring of DVL to the plasma 
membrane by mediating interactions with negatively charged phospholipids at the inner 
leaflet (Wong et al., 2000). The interaction is pH-dependent and is especially important 
for proper WNT/PCP pathway (Simons et al., 2009). DVL has been shown to 
coordinate microtubule assembly during axon differentiation via DEP domain-binding 
to phosphorylated aPKC thus regulating the stability and activity of this kinase (Zhang 
et al., 2007). The DEP domain could further regulate WNT signaling by binding and 
inhibiting the catalytic subunit of the phosphatase PP2A, and the outcome of this 
interaction can have both negative and positive effects on WNT signaling (Yokoyama 
and Malbon, 2007). WNT-5A-induced and clathrin-mediated endocytosis of FZD4 was 
shown to require DVL2-DEP interaction with a subunit of the clathrin adaptor AP-2 
(Yu et al., 2007; Yu et al., 2010). The DEP domain is also responsible for the 
interaction of DVL with the G subunit complex, an association resulting in regulation 
of DVL levels and membrane localization (Egger-Adam and Katanaev, 2010).         
 
1.4.1.4 DVL dynamics and regulation 
DVL hyper-phosphorylation is a hallmark of both WNT/-catenin-dependent and –
independent pathways and can be investigated by an electrophoretic mobility shift of 
DVL during migration in SDS-PAGE. However, the mechanism and significance 
behind this event is not completely understood and current data also suggests that 
polyubiqitination of DVL plays a part in regulation of DVL activity and consequent 
downstream WNT signaling (Angers et al., 2006; Ding et al., 2013; Gao and Chen, 
2010; Sun et al., 2001; Takada et al., 2005; Tauriello et al., 2010).    
 
DVL is dynamic with regard to its subcellular localization and different pools of DVL 
can be identified: cytoplasmic DVL often exists as dynamic multimers or aggregates, 
referred to as punctae (Gao and Chen, 2010; Schwarz-Romond et al., 2005), which 
upon WNT-5A-dependent and CK1-mediated phosphorylation are dispersed giving an 
even distribution of DVL molecules within the cytoplasm (Bryja et al., 2007d). On the 
other hand, WNT-3A-stimulated phosphorylation of DVL3 stabilized punctate 
distribution and formation of DVL-Axin-containing supermolecular complexes 
(Yokoyama et al., 2012). Furthermore, DVL punctae have in some cases also been 
suggested to represent vesicle-bound molecules (Capelluto et al., 2002; Park et al., 
2008). Yet another pool of DVL (often in its phosphorylated state) is found at the 
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plasma membrane where it interacts with FZDs and other membrane-bound proteins, 
e.g. the G complex, to mediate further WNT-signal transduction (Axelrod et al., 
1998; Egger-Adam and Katanaev, 2010; Simons et al., 2009). DVL contains nuclear 
export- and nuclear localization sequences and thus been suggested to translocate into 
the nucleus (Itoh et al., 2005; Weitzman, 2005). Once there, DVL can interact with 
nuclear factors to potentiate transcription of WNT/-catenin target genes (Gan et al., 
2008). However, the notion and significance of a nuclear-confined pool of DVL needs 
to be further evaluated.     
  
Negative feed-back mechanisms are highly important to regulate, terminate and fine-
tune WNT-signaling communication. DVL is the central hub of WNT-signaling and 
therefore, modulation of DVL protein stability and turnover is a powerful means of 
signaling adjustment (Gao and Chen, 2010; Malbon and Wang, 2006). Several proteins 
have been implicated in the regulation of cellular DVL levels, e.g. Dapper1/Dact1, 
Inversin, NEDL1, Prickle-1, KLHL12- and pVHL-E3 (Jung et al., 2009)ubiquitin 
ligases and G subunits (Angers et al., 2006; Cadigan and Nusse, 1997; Carreira-
Barbosa et al., 2003; Chan et al., 2006; Jung et al., 2009; Miyazaki et al., 2004; Zhang 
et al., 2006). DVL has been shown to be degraded in the lysosomal pathway in 
response to a starvation- and/or rapamycin-induced autophagy-related mechanism in 
HEK293 (Gao et al., 2010). Additionally, hyperosmolaric sucrose-mediated inhibition 
of endocytosis resulted in almost complete depletion of DVL, perhaps a mechanism to 
compensate for non-functional internalization and desensitization of WNT cell surface 
components (Bryja et al., 2007a).       
 
1.4.2 Heterotrimeric G proteins – the general effector but 
unconventional WNT/FZD-signaling player 
The immediate downstream effectors of GPCRs are the heterotrimeric G proteins. 
Acting as intermediate signaling units, G proteins are essential mediators of most 
GPCR-evoked physiological responses, e.g. smell, taste, vision, immunity, pain 
perception, neurotransmission and cardiac regulation (Ahmed and Angers, 2013; 
Bockaert et al., 1987; Pierce et al., 2002). Initially, G proteins were not considered to 
participate in developmental signaling pathways, but since it later was found that 
deficiencies in G protein genes can cause embryonic lethality in mice and 
developmental diseases in humans, the important role of G proteins in development is 
nowadays validated (Angers and Moon, 2009; Malbon, 2005, 2011). G protein 
signaling activated by WNT/FZD communication is summarized in figure 1.   
 
The heterotrimeric G protein complex consists of three subunits: , and (Spiegel, 
1987; Stryer and Bourne, 1986). Isoprenylation of - and -subunits anchors the G 
protein complex to the intracellular plasma membrane surface and keeps the trimeric 
complex in close proximity to receptors and other signaling components (Wedegaertner 
et al., 1995). The name G protein refers to the GTPase enzymatic property of the a-
subunit which allows binding and conversion of GTP to GDP. General classification of 
heterotrimeric G protein families is based on the activity profile of the -subunit 
 24 
(Gilman, 1987). However, it is now well known that both the - and -subunits also are 
signaling transducers in their own right (Clapham and Neer, 1997; Dupre et al., 2009; 
Krapivinsky et al., 1995). The human genome encodes 20 -subunit proteins divided 
into four different families: Gs/sXL/gust/olf (Gs for short), Gq/11/14/15/16 (Gq/11), Gi1-3/oA-B/t1-2/z 
(Gi/o), and G12/13 . Further, there are 5 and 12 genes encoding - and -subunit isoforms 
respectively. The signaling process of heterotrimeric G proteins can be described as a 
binary ON/OFF switch, established by the exchange of GDP to GTP at the a-subunit 
(ON signal) and the a-GTPase enzymatic breakdown of GTP to GDP (OFF signal) 
(Oldham and Hamm, 2007, 2008). The ON signal changes the conformation of the a-
subunit leading to the dissociation of the trimeric complex and releases the  and -
subunits (Oldham and Hamm, 2007, 2008).   and  remain in a dimer complex which 
moves on to activate GIRKs and Ca2+ channels, to stimulate PI3K and PLC activity 
and to recruit GRKs2 and 3 (Morris and Malbon, 1999). Signaling relay of a-subunits 
involves the stimulation of adenylyl cyclases and accumulation of cAMP - Gs family, 
stimulation of PLC and breakdown of PIP2 to IP3 and DAG - Gq/11 family, inhibition 
of adenylyl cyclases and modulation of Rap1 activity - Gi/o family, activation of PDEs – 
Gt1-2 and Ggust, and stimulation of Rho-GEFs – G12/13 (Morris and Malbon, 1999; Stryer 
and Bourne, 1986).   The activities of the ON and OFF signals are modulated by 
guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs) 
respectively (Siderovski and Willard, 2005). In this sense, GPCRs can be viewed as a 
GEF, facilitating the exchange of GDP to GTP and activating the G protein signal, 
while factors with GAP activity (regulators of G protein signaling (RGS) proteins) 
stimulates the GTPase activity at the a-subunit thus speeding up the termination of the 
G protein signal (Siderovski and Willard, 2005).  
 
1.4.2.1 Gi/o and WNT signaling 
As mentioned above, G proteins have essential functions in the process of organism 
development and thus are found to be mediators of WNT/-catenin-dependent 
signaling and WNT/PCP/CE/Ca2+ pathways (Bikkavilli et al., 2008; Malbon, 2005; 
Malbon et al., 2001; Schulte, 2010). However, the mechanism linking WNTs to G 
proteins have been debated despite the fact that FZDs, being classified as GPCRs, 
logically could replace the missing link. Studies in X. laevis and Danio rerio using 
pertussis toxin (PTX, from the bacteria Bordetella pertussis) which selectively inhibits 
proteins of the Gi/o family by cysteine ADP-ribosylation of -subunits, showed that 
WNT/FZD signaling could evoke G protein complex dissociation, PLC activation and 
release of intracellular Ca2+ via -subunits (Sheldahl et al., 1999; Slusarski et al., 
1997a). Additional PTX-based studies have provided further evidence of WNT/FZD-
induced Gi/o protein-dependent signaling, via e.g. WNT-3A/FZD1 (Liu et al., 2001). 
Interestingly, WNT-5A/FZD2 was found to activate Gt2 proteins and downstream 
PDEs leading to decline in cGMP levels and Ca2+ signaling (Ahumada et al., 2002). 
Recently, WNT-5A-induced Ca2+ signaling and decreased cAMP levels were shown 
downstream of activated Gi/o proteins in primary microglia (Halleskog et al., 2012). 
Further, -[35S]-GTP-assay, performed at native protein levels, also revealed direct 
activation of PTX-sensitive Gi/o by WNT-5A in the microglia primary culture 
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(Halleskog et al., 2012). Using co-Immunoprecipitation, Gi/o protein dissociation from 
FZD was found to be dependent on WNT-3A stimulation and also involved detachment 
of DVL from FZD (Liu et al., 2005). WNT-3A was also found to induce activation of 
PTX-sensitive Gi/o in brain tissue-derived plasma membrane fractions (Koval and 
Katanaev, 2011). In D. melanogaster Go is recognized as a crucial component of 
WNT/-catenin and WNT/PCP signaling. It was found that WNT/FZD activation of 
Go-GTP recruited Axin from the destruction complex and that by interacted with 
DVL thereby co-operatively inhibiting the breakdown of -catenin (Egger-Adam and 
Katanaev, 2010). Moreover, in experiments using Escherichia coli-expressed and 
reconstituted human FZD1, 6 or 7, WNT-3A, -5A, -5B and -7A were all shown to evoke 
GDP to GTP exchange at Go proteins, albeit at different efficacies depending on the 
receptor subtype (Katanaev and Buestorf, 2009).    
 
1.4.2.2 Gs and WNT signaling 
The role of proteins of the Gs family in WNT signaling is not as extensively studied as 
Gi/o. However, since overexpression of Gs can promote the formation of primitive 
endoderm in mouse totipotent F9 teratocarcinoma cells (Gao et al., 1995) and disturbed 
Gs gene expression is embryonic lethal, the role of Gs in development is established 
(Yu et al., 1998). Moreover, WNT-induced Gs activation was recently shown to 
inhibit migratory properties of breast cancer cells. Activation of FZD3 by WNT-5A was 
able to evoke adenylyl cyclase-mediated production of cAMP leading to PKA-
dependent inhibition of migration (Hansen et al., 2009). The WNT-induced Gs-
mediated cAMP/PKA pathway was also shown to activate myogenic gene expression 
(Chen et al., 2005) and a genetic interaction between Gs and D. melanogaster FZD1 
was recently established by analyzing R3/R4 photoreceptor differentiation (Nichols et 
al., 2013).    
  
1.4.2.3 Gq/11 and WNT signaling 
Activation of Gq/11 typically leads to the activation of PLC and downstream 
intracellular Ca2+ mobilization (Morris and Malbon, 1999). Given the canonical 
outcome of Gq signaling, it could be expected to mainly be associated with the 
WNT/Ca2+ pathway. However, data demonstrate a clear link between Gq/11 and -
catenin pathway (Gao and Wang, 2007; Liu et al., 2001; Liu et al., 2005). It was e.g. 
shown that RNAi knock-down of Gq effectively disrupts WNT-3A-mediated and 
FZD1-dependent stabilization of -catenin in F9 cells (Liu et al., 2001). Moreover, the 
role of Gq/11 in development is validated since Gq/11 double knockout mice results in 
embryonic lethal phenotype (Offermanns et al., 1998) and Gq is involved in the process 
of axon guidance in D. melanogaster (Ratnaparkhi et al., 2002). Also, WNT-3A-
mediated regulation of bone formation was shown to be transduced via a Gq/11-PKC 
pathway (Tu et al., 2007).     
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1.4.2.4 G12/13 and WNT signaling 
The G12/13 proteins are regulators of Rho-GTPase GEFs thereby promoting Rho-
mediated cell fates, such as activation of MAPK signaling cascades and cytoskeletal 
rearrangements (Malbon, 2005). In C. elegans G12 mediates embryonic development 
and axon guidance (Yau et al., 2003) and disrupted gene expression of G13 causes 
embryonic lethality in mice (Offermanns et al., 1997). However, besides the 
importance of G12/13 proteins in developmental processes not much is known about the 
connection between this G protein family and WNT/FZD on the molecular level.  
 
1.4.2.5  G and WNT signaling 
The study of specific roles of G-isoforms are difficult to disipher due to high 
functional rendundancy within the groups of - and -subunits (Malbon, 2005). In 
development the G complex has mainly been associated with centrosome function 
and spindle organisation and thus are imortant mitotic factors (Malbon, 2005; 
Vanderbeld and Kelly, 2000). In X. laevis mesodermal CE movements dependent on 
WNT-11/FZD7 activation of Cdc42, G-subunits were shown to play a key regulatory 
role (Penzo-Mendez et al., 2003). In some WNT-coordinated cell signaling events, and 
on a molecular level, G is also shown to interact with and regulate DVL funcion and 
loclization (Angers et al., 2006; Egger-Adam and Katanaev, 2010; Jung et al., 2009). 
Free G-subunits have further been shown to recruit GSK-3 to the plasma membrane 
to coordiante subsequent LRP6 phosphorylation by GSK-3 (Jernigan et al., 2010).  
Recently, Halleskog et al showed that a WNT-5A-induced and PLC-mediated Ca2+-
regulated ERK-1/2 phosphorylation pathway in primary mouse microglia was blocked 
by the use of the -specific inhibitor M119. Interestingly the study also showed that 
this signaling pathway was PS-DVL-independent since the CK1 inhibitor D4476 did 
not affect the activation of ERK1/2 (Halleskog et al., 2012). Moreover, it has been 
postulated that the impact of G in WNT/FZD signaling might be more profound than 
perviously thought and that FZDs perhaps employs a G-signaling mechanism similar 
to that of yeast pheromone receptors (Angers and Moon, 2009).   
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1.4.2.6 Comments on G protein – FZD interaction 
Direct contact between heterotrimeric G proteins and their designated 7TMR is 
required in order to achieve signal transduction. Analysis of mammalian 
phototransduction at rhodopsin receptors provided evidence of a random collision 
model of receptor-G protein interaction where freely diffusing G proteins frequently 
and transiently make contact with receptors (Arshavsky et al., 2002). Currently, 
however, a growing body of data supports a second model in which the 7TMR is 
precoupled or preassembled with the G protein in relatively stable but still dynamic 
complexes (Neubig, 1994; Rebois and Hebert, 2003). The second model is attractive 
since 7TMRs have been found confined to microdomains of clustered receptors, co-
receptors and intracellular effectors. Moreover, such a confinement should logically 
decrease the rate of diffusion and increase the limitation of successful collision events, 
thus resulting in slower signal transduction (Choquet and Triller, 2003). However, 
experimental data show that the speed of GPCR signaling is unaffected even if the 
receptor is immobilized, indicating that transduction, in some cases, not is diffusion-
limited (Lober et al., 2006). The way in which FZDs contact G proteins remains to be 
evaluated and might differ depending on the G protein species and the FZD isoform. 
The work of this thesis, however, provides evidence for the precoupling model of FZD-
G protein interaction. 
 
Through mining of bioinformatics data, computational predictions of FZD-G protein 
interactions can be conducted. Using artificial neuronal network algorithm Koval and 
colleagues reported that all FZD isoforms were predicted to couple to Gi/o proteins and 
Figure 1. Summary of WNT/FZD signaling to heterotrimeric G proteins evoking either -catenin-
dependent- (A) or -catenin-independent pathways (B). 
 28 
to some extent also to Gq in the case of FZD4, 5 and 6. In conclusion, the in silico, as 
well as the biochemical data suggests that, out of the four different families of G 
proteins, the Gi/o family have the most profound role in the WNT/FZD cell 
communication system (Halleskog et al., 2012; Kilander et al., 2011a; Kilander et al., 
2011b; Koval and Katanaev, 2011; Koval et al., 2011; Wang et al., 2006).   
 
1.4.3 Additional WNT/FZD-signaling molecules – Axin and -arrestin 
Even though many of the WNT signaling mediator molecules and their respective 
position in the chain of WNT communication events are known, the processes of 
activation, transduction and direct interactions between the components remain, in 
many cases, obscure (Angers and Moon, 2009; van Amerongen, 2012). The 
composition and regulation of the -catenin destruction complex and the signaling 
events of the -catenin dependent pathway are among the more well-studied features of 
WNT-communication.  
 
1.4.3.1 Axin 
As mentioned earlier, the destruction complex is the molecular machinery responsible 
for inhibiting accumulation of -catenin in the absence of WNTs. Working as the 
scaffold of the destruction complex, Axin is a key molecule in WNT/-catenin 
signaling and exert negative regulation by binding directly to GSK3, CK1, APC, -
catenin and additional factors of the destruction complex (Luo and Lin, 2004). 
Activation of FZDs by -catenin signaling WNTs leads to relocation of Axin mediated 
by direct interaction with phosphorylated LRP5/6 intracellular domains (Davidson et 
al., 2005; Mao et al., 2001; Zeng et al., 2005), by the interaction with the DVL-DIX 
(via the Axin-DIX) domain (Cliffe et al., 2003; Schwarz-Romond et al., 2007b) and by 
direct binding to Go-GTP (Egger-Adam and Katanaev, 2010). Axin contains a RGS 
domain which is mediating the contact with Go as well as APC. RGS domains 
commonly also harbor a GAP catalytic function thus accelerating the G GTPase 
activity (Natochin et al., 1998). However, this function of the Axin RGS domain is so 
far believed to be either lacking or to require additional factors (Schneider et al., 2012). 
The Axin-RGS was recently shown to have differential roles in axis induction and 
anteriorposterior neural tissue patterning indicating that it is the protein repertoire of a 
specific cellular system that determines the nature of the Axin-G protein signaling 
(Schneider et al., 2012). Axin has further been suggested to interact with G-subunits 
from the Gs, Gq and G12/13 families (Castellone et al., 2005; Stemmle et al., 2006), 
showing a more general function of Axin to cooperate with G proteins, perhaps even 
outside of WNT signaling events .    
  
1.4.3.2 β-arrestin        
β-arrestin1 and -2 are highly interesting and important GPCR-associated scaffold 
proteins and were first identified as factors promoting clathrin-mediated rhodopsin- and 
adrenergic receptor desensitization, thus arresting further signaling transduction 
(Attramadal et al., 1992; Lohse et al., 1990). However, -arrestins harbor additional 
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functions essential for localization and pathway specification of 7TM receptors. 
Moreover, the role of β-arrestins in pharmacological research is appreciated since it 
was found that exogenous ligands to 2-adrenergic receptors (2AR), angiotensin II 
type 1 receptors, μ-opioid receptors, chemokine receptors and PTH1R selectively 
activated G protein-independent signaling via -arrestins (Drake et al., 2008; Violin 
and Lefkowitz, 2007). The functions of -arrestins as signaling effectors and scaffolds 
as well as mediators of agonist-activated internalization are shown to be present in both 
-catenin-dependent and -independent WNT/FZD signaling (Bryja et al., 2007b; Chen 
et al., 2001; Chen et al., 2003; Kim and Han, 2007; Kovacs et al., 2009; Schulte et al., 
2010). For example, -arrestins interacts with Axin and DVL to form a ternary 
complex necessary for WNT-3A/-catenin signaling and is essential for WNT-5A 
stimulated CE signaling to Rho and Rac (Bryja et al., 2007b; Kim and Han, 2007). As 
arrestin1/2 double knock-out MEFs failed to execute WNT-3A-induced DVL 
phosphorylation, -arrestin might have an important role in the process of DVL 
phosphorylation (Bryja et al., 2007b). WNT-mediated -arrestin signaling at FZDs 
includes unconventional mechanistic features compared to -arrestin signaling at other 
7TM receptors. Interestingly, phosphorylated DVL is required as an adapter between 
FZD and -arrestin to allow WNT-5A-induced internalization of FZD4, again 
highlighting the unusual modes of signaling connected to Class F GPCRs (Chen et al., 
2003). 
     
1.5 WNT/FZD PHARMACOLOGY 
 
1.5.1 WNT/FZD signaling and disease 
The coordination of important cell fates, such as cell proliferation, differentiation, 
migration and apoptosis are mediated by the WNT/FZD signaling system and thus, 
aberrant WNT/FZD communication has been linked to severe diseased states in 
humans (Logan and Nusse, 2004). Dysfunctional regulation of WNT/FZD signaling is 
currently linked to cancer, neurodegenerative diseases, inflammatory diseases, and 
disorders caused by erroneous bone metabolism and endocrine function (Inestrosa et 
al., 2012; Marchetti and Pluchino, 2013; Regard et al., 2012; Zimmerman et al., 2012). 
Manifestation of WNT/FZD-related disease can be the cause of changes in expression 
of WNTs and secreted WNT modulators or of mutations in WNT signaling 
components (MacDonald et al., 2009). FZDs, established as the main WNT receptor, 
are directly downstream of WNTs and thus malfunctioning FZD proteins will impose 
severe effects on WNT-induced cell fates (Huang and Klein, 2004; Schulte, 2010). The 
knowledge of proximal WNT-signaling, at the level of receptor transduction, is still 
lacking several steps in the mechanistic and dynamic regulation of FZDs. Hence, the 
correlation between dysfunction in FZD signaling and disease is problematic to 
establish. A few pathogenic mutations and alterations in gene expression have currently 
been linked to the genes encoding FZD isoforms. For example, genetic connection 
between FZD3 and schizophrenia (Kang et al., 2011) has been demonstrated and the 
correlation between mutations in the fzd4 gene and disruption in retinal angiogenesis in 
familial exudative vitreoretinopathy is well-established (Robitaille et al., 2002; Wang et 
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al., 2012; Yang et al., 2012). Several alterations in the nucleotide sequence and in the 
regulation of the FZD6 gene are linked to aberrant nail formation, development of 
chronic lymphocytic leukemia, neural tube defects, depression and aggressive 
neuroblastoma tumors (Cui et al., 2013; De Marco et al., 2012; Frojmark et al., 2011; 
Naz et al., 2012; Raza et al., 2013; Voleti et al., 2012; Wu et al., 2009). Also, 
FZD3/FZD6 double knockout mice show severe defects in midbrain development 
(Stuebner et al., 2010). In general, several human cancers can readily be found in 
connection with altered levels of FZD expression (Katoh, 2005; King et al., 2012; 
Nagayama et al., 2009; Ueno et al., 2013; Vincan, 2004). 
 
Collectively, the data regarding WNT signaling-related diseases clearly establishes a 
need for drugs targeting events in the scheme of WNT communication and attractive 
molecular targets, from a pharmacological point of view, are proteins in the FZD 
family. The development of drugs requires an understanding of the pharmacological 
properties of WNTs and FZDs, and to date the volume of information in this area of 
WNT/FZD signaling is very sparse (Schulte, 2010).     
 
1.5.2 Pharmacological aspects and druggability of FZD signaling  
FZDs belong to the 7TMR superfamily which is the most common target of 
pharmaceutical compounds (Whalen et al., 2011). Currently, the methods developed to 
target WNT signaling at the FZD level involves targeting and inhibiting extracellular 
agonist stimulation or interfering with receptor binding to intracellular effectors 
(Zimmerman et al., 2012). The former approach includes the use of FZD isoform-
specific antibodies (Fukukawa et al., 2008; Sen et al., 2001; Weeraratna et al., 2002), 
SFRPs, WNT protein mimetic compound (FOXY-5) and antagonist (BOX-5), and 
purified WNTs (Jenei et al., 2009; Minear et al., 2010; Nostro et al., 2008; Safholm et 
al., 2006; Safholm et al., 2008; Vijayaragavan et al., 2009; Willert et al., 2003), while 
the latter method, being more difficult to target, mainly focus on compounds blocking 
PDZ domain-PDZ ligand binding (Fujii et al., 2007).       
 
In the pursuit to successfully develop novel WNT/FZD targeting drugs, the concept of 
receptor agonist-specific binding properties needs to be explored. As mentioned earlier, 
the ternary complex model is used to explain the shifts in ligand affinity of the 7TMRs 
due to the GTP-dependent interaction with heterotrimeric G proteins and currently the 
model is often extended to include additional receptor complex states and used to 
simulate allosteric regulation of receptors (Kenakin and Christopoulos, 2013). Several 
such models exists for specific Class A GPCRs, however, owing their unconventional 
features in G protein signal transduction, models explaining the cooperative 
interactions of FZD-ligand-effector are not easy to construct (Schulte, 2010). In the 
same manner of conventional GPCRs, which are shown to mediate effects via G 
proteins or -arrestin, FZDs might be able to transduce signals via either DVL or G 
proteins. However, due to overlapping binding sites and to spatial limitations it seems 
unlikely that DVL and G proteins would make contact with FZDs at the same time. 
Hence, three hypothetical working models of FZD-DVL-G protein signaling are 
currently being discussed and proposed by our research group (fig. 2): i) the 
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competition model, ii) the temporal model, and iii) the compartment model (Schulte, 
2010; Schulte and Bryja, 2007). The competition model assumes that DVL and G 
proteins are competing for the same interaction site at FZD and that signaling only 
occurs via one of the two effectors within one round of agonist stimulation. The 
temporal model suggests that signaling via G proteins might occur fast while signaling 
by DVL has a slower rate of transduction, however, agonist stimulation of the receptor 
leads in this case to activation of both effectors. The compartment model theorizes that 
the two effectors reside at different receptors but might cooperate in a higher order 
complex, in response to agonist stimulation, to execute signaling, i.e. receptor 
homo/heterodimerization might occur (Schulte, 2010; Schulte and Bryja, 2007).  
Experimental validation of these models with respect to a specific WNT and FZD 
isoforms would improve the chances of drug development in the WNT field.     
 
 
 
 
 
 
 
Closely related to the above suggested models is the concept of functional selectivity or 
biased agonism. It has been shown that conventional GPCRs, such as e.g. the µ-opioid 
receptor, the angiotensin (AT1) receptor, muscarinic acetylcholine (M1) receptos and 
the PTH1 receptor, can signal to different pathways (i.e. β-arrestin-mediated or G 
protein-dependent) depending on ligand-specific stabilization of a certain receptor 
conformations (Violin and Lefkowitz, 2007). Thus, it showed that the concept of 
correlated efficacies was insufficient to explain the many aspects of ligand-receptor 
signaling outcomes (Kenakin, 1995). The idea of ligand bias or functional selectivity 
was thereby accepted and describes receptor function and effector coupling as a 
consequence of the preference of ligand-bound receptors to reside at a unique subset of 
all possible conformational states. Conversely, for unbiased ligands, regardless of the 
functional outcome, the subset of conformational states stabilized are identical 
(Kenakin, 2005). Ligand bias can be calculated using two different approaches: the 
pharmacological model and the allosteric model. The former employs the concept of 
affinity-driven efficacy (i.e. the ability of agonists to form an agonist-receptor complex 
to induce a cellular response) to compare the performances in so called biased plots 
where an agonist’s response in one assay is plotted against the response in a second 
assay at equimolar agonist concentration (Kenakin and Christopoulos, 2013). The 
Figure 2. Schematic representation of the hypothetical models for FZD-G protein and DVL interaction: 
the competition model (A), the temporal model (B), and the compartment model (C).  
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allosteric model accounts for the concepts of low and high affinity states of agonists 
and receptors and the formation of a ternary complex as a consequence of effector 
presence. Thus in the latter model the ligand efficacy is defined by the agonist’s ability 
to induce the formation of a functional ternary complex and it is ultimately the 
composition of this complex which determines signaling outcome. In the 
pharmacological model signaling pathway selection is dependent only on the agonist 
(Rajagopal, 2013). As the name denotes, ligand bias is conditional with regard to the 
fact that it must be used in the context of another ligand. Ideally, such a standard ligand 
would be an endogenous agonist. However, endogenous ligands, themselves, are in 
most cases not devoid of biased signaling. In drug discovery research both endogenous 
and synthetic ligands are used as reference compounds when calculating ligand bias 
(Kenakin and Christopoulos, 2013).  
 
The current goal in drug discovery is to develop ligands which selectively will activate 
one signaling pathway without affecting the other, thus minimizing the chances of 
unwanted and negative side-effects. In a clinical therapeutic context biased agonists are 
proven superior in the treatment of several conditions such as chronic pain, heart 
failure, metabolic- and psychiatric disorders and cancer (Kenakin and Christopoulos, 
2013). Considering the many possible effects induced by WNTs and the growing body 
of data showing differential signaling properties of WNT isoforms in a specified 
cellular milieu, the concept of ligand bias could certainly be adopted to provide insights 
into WNT-pathway selectivity and aid the screening for new ways to target WNT/FZD 
signaling. 
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2 SPECIFIC AIMS 
 
 
 
‐ To establish the potential of WNTs to activate heterotrimeric G proteins  
 
‐ To investigate aspects of functional selectivity among WNT-isoforms using 
functional assays and live-cell imaging techniques in endogenous and protein 
expression modified cellular milieus. 
 
‐ To compare pathogenic FZD6-R511C missense mutant to wild type receptors 
with respect to functional and molecular properties. 
 
‐ To assay WNT/FZD binding selectivity and signaling efficacy. 
 
‐ To elucidate the nature of mechanistic interactions between FZDs and G 
proteins by using FZD6 as a representative for Class F receptors. 
 
‐ To clarify the role of DVL in the liaison between FZD6 and G proteins.   
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3 MATERIALS & METHODS 
 
This part of the thesis will mainly deal with additional comments and considerations 
regarding the methods and materials used. Detailed descriptions of the experimental 
procedures are found in the designated sections in each article.  
 
Method/Technique Paper Protocol adopted/modified from 
ref 
Cell culture propagation I -V (Halleskog et al., 2011; Schulte et 
al., 2005) 
Plasma membrane fraction isolation I-II (Lazareno, 1997) 
Cell permeabilization I (Lane et al., 2008; Schulz, 1990) 
Molecular cloning III, V In-house protocol 
DNA/RNAi transfection of cells I, III, 
IV, V
(Bryja et al., 2007b; Gesty-Palmer et 
al., 2006)/in-house protocol 
Inhibitor-treatment/WNT-stimulation I-V (Schulte et al., 2005)/in-house 
protocol 
RT-PCR/ QPCR I, II, III (Halleskog et al., 2011) 
-[35S]-GTP assay I-II (Cooper et al., 2009) 
Cell counting I, III In-house protocol 
MTT-assay I-II (Mosmann, 1983) 
Native-PAGE/immunoblotting I (Wittig et al., 2006) 
SDS-PAGE/immunoblotting I-V (Halleskog et al., 2011) 
Immunoprecipitation I, III (Bernatik et al., 2011) 
Immunocyto- and histochemistry/X-Gal 
staining 
III, V (Guo et al., 2004; Schulte et al., 
2005) 
Genotyping/genetic linkage 
analysis/sequencing 
III (Entesarian et al., 2009; Klar et al., 
2009) 
Single fluorophore FRAP IV (Phair et al., 2004) 
Double fluorophores FRAP/surface 
cross-linking 
V (Qin et al., 2011; Qin et al., 2008) 
Live cell imaging III, V In-house protocol 
Acceptor photobleaching FRET III, V (Goedhart et al., 2007) 
 
 
 
3.1 METHODOLOGICAL CONSIDERATIONS  
3.1.1 Propagation of primary- and cell-line cultures 
The experiments comprising this thesis were mainly performed in in vitro cell cultures. 
Immortalized cell lines (HEK293T and N13) were allowed to undergo maximum 20-30 
passages before being discarded. Cells were checked regularly for mycoplasma 
infection using RT-PCR detection (primers from Sigma) and cultures proven positive 
for mycoplsma were either terminated or treated with Plasmocin until tested negative. 
Table 1. Methods used in this thesis. 
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Mycoplasma infection has been shown to severely affect cellular responses (Rottem 
and Barile, 1993; Uphoff et al., 2012) and we also experienced this complication first 
hand when trying to optimize the [-35S]GTP assay in N13 cells (J.P. Dijksterhuis and 
M. Kilander  unpublished observations). 
 
3.1.2 Preparation of membrane fractions and cell permeabilization 
Plasma membrane fractions were isolated from N13 using either Polytron disruption 
and high speed centrifugation or a commercially available plasma membrane protein 
extraction kit (Fermentas). The degree of “purity” of the plasma membrane fractions 
with respect to intracellular, soluble proteins, in particular DVL, was observed to affect 
the magnitude of [-35S]GTP incorporation. Membranes contaminated with DVL 
performed poorly whereas fractions devoid of DVL showed high activity in the [-
35S]GTP assay. It is tempting to suggest that the presence of DVL might disturb WNT 
signaling to G proteins by mechanisms of competition at FZDs, however, the result 
observed might also be the consequence of a dilution factor, i.e. the total protein 
concentration of the fraction will consist of a smaller pool of receptors and membrane-
associated molecules if intracellular proteins are present. Plasma membrane fractions 
contaminated with DVL were subjected to an additional round of isolation by 
centrifugation. Furthermore, formation of plasma membrane micelles will yield a 
random orientation of membrane-imbedded proteins; a situation in which some 
receptors will be positioned inside-out, in the wrong direction. Thus, just prior to 
addition of assay constituents, membrane preparations were briefly sonicated at low 
strength. Cell plasma membrane permeabilization was done using 0.00025% (w/v) 
saponin since this concentration was reported to not affect intracellular membranes 
(Schulz, 1990). By immunoblotting it was observed that cells, after being subjected to 
saponin permeabilization, were depleted of DVL. 
 
3.1.3 Overexpression systems versus native conditions 
The possibility to perform molecular cloning and express exogenous genes in cells and 
organisms has greatly improved the study of protein interaction, function, dynamics 
and structure. However, most cellular processes are highly fine-tuned and sensitive to 
changes in protein component concentration or function (Atwood et al., 2011). The 
plausible consequences of artificial overexpression of proteins are many; e.g. forced 
protein-protein interactions, impaired protein sorting, trafficking and digestion, 
disturbed protein localization, under/over activation of signaling pathways, and even 
necrosis (Adamson et al., 2011). Thus when studying cell communication the 
introduction of exogenous genes needs to be done with caution and is reliant on a sound 
set of controls. The use of native cellular conditions will circumvent these problems 
and results obtained from overexpression systems should ideally be validated in an 
endogenous milieu. Native conditions, on the other hand, require the availability of 
high-performing molecular tools, such as e.g. antibodies, and can often be difficult to 
evaluate.         
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3.1.4 Assays of G protein activation  
The investigation of direct agonist-induced G protein activation was done by 
measurement of [-35S]GTP or -S-GTP incorporation in two ways: i) classical 
evaluation GTP bound G-subunits by counting -particle emission, ii) quantification 
using antibody-recognition of GTP-Gi in combination with SDS-PAGE/ 
immunoblotting under native conditions. The former technique is well-established and 
has been used for a variety of GPCRs to measure agonist activity on G proteins from at 
least three of the four families. However, the [-35S]GTP assay is most suited for Gi/o 
coupled 7TMRs since Gi/o proteins, compared to G proteins from other families,  
usually are more abundant and have higher GDP to GTP exchange rates which thus 
yields a higher signal to noise ratio (Harrison and Traynor, 2003). The [-35S]GTP 
assay is performed in the presence GDP, Mg2+ and Na+. GDP is added to decrease the 
basal incorporation of [-35S]GTP so that the resolution of agonist-induced G protein 
activity increases. The amount of GDP needed varies between experimental systems 
and the optimal concentration has to be titred out (Harrison and Traynor, 2003). The 
presence of Mg2+ ions, in the low mM range, is essential for GDP-GTP exchange and 
potentiates both basal and agonist-induced GTP binding but has a greater effect on 
agonist-evoked G protein activation (Birnbaumer and Zurita, 2010). Na+ ions are not 
required but has been reported to have an effect on the signal to noise ratio by favoring 
agonist-stimulated [-35S]GTP binding over basal. The use of immuno-based 
techniques to measure G protein activation is a fairly new approach and obviously 
requires antibodies that are able to distinguish between the active (GTP-bound) and 
inactive (GDP-bound) states. Recently the lab of G. Milligan managed to produce such 
tools and currently Gi-GTP antibodies, which are commercially available, are shown 
to perform well in immune-based assays, e.g. immunoprecipitation (Lane et al., 2008). 
However, caution is advised in respect to cell disruption protocols since all use of 
denaturizing agents will destroy the native conformation of the G protein thus 
depriving the antibody of its epitope.              
 
3.1.5 Immuno-based assays to measure WNT-activity 
Activation of WNT-signaling pathways induces a number of protein modifications and 
a number of these can be studied using phospho-specific antibodies. The 
phosphorylation of LRP5/6 is a hallmark of WNT/-catenin signaling and good 
antibodies exist which can recognize this modification. However, the most common 
method to assay -catenin-dependent signaling is to measure the levels of -catenin and 
preferably use antibodies that only detect the active (dephosphorylated) -catenin, so 
called ABC antibody. On the other hand, in cells with low basal -catenin 
concentrations the use of the ABC antibody is not necessary. The detection of the 
electrophoretic mobility shift of DVL, referred to as PS-DVL (phosphorylated- and 
shifted-DVL), is a common approach to evaluate WNT-stimulation, however it is not 
known whether this modification is directly correlated to pathway activation or not. 
Moreover, the shift of DVL is usually considered the result of a hyper-phosphorylation 
but might also be indicative of ubiqitination. Downstream signaling events can also be 
evaluated using phospho-specific immuno-based analysis, such as activation of 
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MAPKs, e.g. ERK1/2, p38 and JNK. In particular ERK1/2 used as common readouts of 
PTX-sensitive Gi/o activation. Recently, Halleskog et al showed that WNT-induced 
phosphorylation of ERK1/2 was mediated via Gi/o proteins in primary microglia 
(Halleskog et al., 2012). Therefore, in article V, the phosphorylation of ERK1/2 was 
used to test WNT-5A-induced pathway functionality in HEK293.          
 
3.1.6 MTT-assay 
Classically, MTT-assay is a method developed to evaluate cell viability and is 
performed by measuring the switch in absorption wavelength of 3-(4,5-dimetylthiazol-
2-yl)-2,5-diphenyl-tetrazoliumbromide (MTT) when its tetrazolium ring is cleaved by 
complex II (succinate dehydrogenase) in the mitochondrial respiration chain. Light 
absorption is read at 592 nm and corresponds to the functional state of mitochondria 
(Mosmann, 1983). Apart from cell viability, this assay is used to evaluate cell 
proliferation and was employed for this purpose in article II. In respect to proliferation, 
results obtained from an MTT-assay must be considered carefully since it correlates to 
the number of functional mitochondria and not to the number of cells in the culture. 
However, results of WNT-5A-induced proliferation obtained from manual cell 
counting (article I) and from the MTT-assay (article II), were comparable in outcome 
and thus we decided to use MTT-assay for evaluation of WNT-induced proliferation.   
  
3.1.7 Fluorescence recovery after photobleaching (FRAP) 
FRAP is a technique to study fluorescent particle mobility. With the discovery of 
fluorescent proteins and advances in molecular cloning this technique is widely used in 
biomolecular research. Proteins of interest are fused to fluorophores and can thus be 
monitored using live-cell imaging with fluorescent microscopes. Protein mobility is 
measured by correlating fluorescence intensities before and after high-intensity laser 
illumination of a region of interest. The illumination irreversibly incapacitates, 
bleaches, the fluorophores and perturbs the equilibrium of fluorescence intensity. If the 
proteins under investigation are mobile, a new equilibrium will be reestablished and the 
rate as well as the degree of fluorescence recovery correlates to diffusion ability in the 
medium the protein resides in (i.e. lipid membrane or cytoplasm), its association with 
subcellular structures and organelles, and its presence in protein complexes (Sprague 
and McNally, 2005). In this way FRAP has successfully been used to study molecular 
dynamic related to changes in mobility of transmembrane receptor proteins (Aguila et 
al., 2011; Kaczor and Selent, 2011). In article IV we employed conventional FRAP 
analysis to study the effect of WNT-stimulation on the mobility of FZD6-GFP fusion 
proteins. In article V the FRAP approach was further developed to allow for the 
analysis of two fluorophore-fused proteins simultaneously. The technique, which also 
makes use of biotin-avidin mediated cross-linking of cell surface lysine residues and 
primary amines, was developed by N. Lambert and colleagues and has been used to 
study several aspects of GPCR and G protein molecular features. Functionality of the 
receptors tested was found unaffected by the cross-linking procedure and the method 
was validated using different G-subunits, nucleotide depletion and different rations of 
components (Fonseca and Lambert, 2009; Lambert, 2009; Lober et al., 2006; Qin et al., 
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2011; Qin et al., 2008). Ideally, for this FRAP method to detect transient protein 
interactions the cross-linked and immobilized partner should be present in excess 
compared to the mobile component.   
 
 
 
 
3.1.8  Acceptor photobleaching Förster resonance energy transfer 
(pbFRET) 
Non-radiative energy transfer of an excited state from one fluorophore to another 
constitutes the basis of FRET and is today a common method to measure protein-
protein interactions due to its distance-dependent features. FRET only occurs when a 
fluorophore pair, with appropriate spectral overlap, is situated within less than10nm of 
each other. A FRET pair consists of a donor fluorophore which is excited with light at 
the proper wavelength to transfer resonance, or vibrational, energy to the acceptor 
fluorophore. The process can be detected as acceptor molecule fluorescence. Through 
mathematical description of the FRET phenomenon the Förster radius Ro can be 
obtained and is defined as the characteristic distance between a given fluorophore pair 
at which FRET efficiency is 50%. The typical Ro distance is somewhere around 4-6 
nm. The positions of the fluorophores, and their relative dipole movements towards 
each other, also affect the FRET efficiency. A parallel orientation is more likely to 
result in FRET than a perpendicular one. Thus, false negative results, in respect to 
protein-protein interaction, can be obtained. For example, in article V, FRET between 
the receptor and G-subunit was performed since only a minute FRET efficiency was 
observed between the G-subunit and the receptor. The most commonly used FRET 
pair are the cyan fluorescent protein (CFP) and yellow fluorescent protein (YFP) 
fluorophores, however, some features, such as autofluorescence from CFP excitation 
and decreased endurance of measurement due to multiexponential decay of CFP, have 
led to the search for other suitable and high-performing FRET pairs. In article III and V 
green-red (green fluorescent protein (GFP) – mCherry) FRET pairs have been used 
Figure 3. Representative FRAP results. (A) 
Typical recovery curve obtained after cell surface 
cross-linking, II is the initial intensity, Io is the 
imitate intensity post-bleaching and IP denotes 
recovering intensities. (B) Photomicrographs of 
the bleaching procedure of an area in HEK293 
plasma membrane. 
A B 
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since i) moving excitation wavelength towards the red spectra generally decreases 
autofluorescence, ii) FRET efficiency usually increases for pairs at higher wavelengths 
(Albertazzi et al., 2009; Goedhart et al., 2007), and iii) limitations in laboratory 
equipment made the measurement of CFP/YFP FRET not feasible. The method of 
donor dequenching after acceptor photobleaching (pbFRET) is a robust, simple and 
well-established modification of the FRET protocol and is most commonly performed 
in fixed cells. Donor dequenching will increase the fluorescence of the donor if the 
bleached acceptor is within FRET distance. Drawbacks of this method include 
limitation in repeated measurements and the loss of information regarding dynamic 
protein interactions (Piston and Kremers, 2007).  
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4 RESULTS & DISCUSSION 
 
4.1 WNT-INDUCED G PROTEIN ACTIVATION AND ISOFORM-SPECIFIC 
SIGNALING IN A DEFINED CELLULAR SYSTEM 
 
As stated earlier, the mammalian WNT/FZD signaling system (consisting of 19 ligands 
and 10 receptors) allows for a high number of possible interaction partners able to 
activate a variety of different down-stream signaling pathways. Physiologically, the 
determination in WNT-FZD isoform pairing and in WNT pathway preferences seems 
to be orchestrated by the unique, local or temporal, protein expression in a specific 
tissue (Niehrs, 2012; van Amerongen, 2012). Moreover, WNT action occurs both at 
short distances in an autocrine and paracrine manners or at longer distances of up to 
more than 20 cell diameters (Port and Basler, 2010). This feature, in combination with 
stringent control of expression of signaling components, allows WNTs to perform a 
specific process within a defined area at a precise time point. Such precision is a 
prerequisite for the morphogenic role of WNTs (Gordon and Nusse, 2006; Nusse, 
2012). In the first paper we analyzed the expression of WNT signaling receptors and 
co-receptors in a specific cell line derived from microglial linage. The analysis revealed 
the presence of a unique set of signaling components able to produce high response to 
WNT-5A stimulation.  Thus, in the second article we decided to use this cellular system 
as a platform to further investigate WNT isoform-specific differences in signaling 
activation at endogenous protein stoichiometry. 
       
 
 
 
 
 
Figure 4. Assessment of WNT signaling-related components in N13. (A) QPCR analysis of 
expression levels of  FZD isoforms present in N13. (B) Lack of ROR1 expression compared 
to B-cell lymphoma line (BCL), confirmed by immunoblotting. (C) RT-PCR screening of 
PTX-sensitive Gi/o isoforms.   
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4.1.1 WNT-5A activates PTX sensitive heterotrimeric Gi2/3 proteins in 
microglia like cells (Paper I) 
 
As discussed previously, analysis of the role of heterotrimeric G proteins in WNT 
signaling transduction has received relatively little attention in the WNT signaling 
research field. In the present paper we choose to investigate guanine nucleotide 
exchange by an accumulative read-out assay, [-35S]GTP. This assay was developed in 
the early 1980s and has proven a robust and reliable method to study GPCR signaling 
and especially the activation of Gi/o proteins. Presently, however, alternative methods 
have largely replaced the [-35S]GTP assay because of the handling of radioactive 
emission from the [35S]-isotope (Koval and Katanaev, 2012). In our hands, this assay 
proved to be efficient and sensitive enough to detect WNT-5A-induced exchange of 
GDP to GTP at heterotrimeric G-subunits. Hence, in this article we are able to show, 
for the first time, that WNTs are able to activate and relay signal transduction via G 
proteins in endogenous cellular systems devoid of potential artifacts created by protein 
overexpression.  
 
Using isolated plasma membrane fractions from N13, a microglia-like immortalized 
cell line, we retain only the most proximal, plasma membrane tethered, WNT-signaling 
components. Thus, we are able to exclude WNT-induced effects on most cytosolic 
small GTPases as well as possible competition by DVL-directed signaling. The first 
notion that WNT-5A might activate G protein signaling was obtained from our 
discovery that N13 proliferative response to WNT-5A stimulation was PTX sensitive. 
Rapid proliferation is an important physiological feature of microglia to regulate 
inflammatory processes and studies in our lab have revealed microglia-modulating and 
immunological potentials of WNTs (Halleskog et al., 2012; Halleskog et al., 2011; 
Halleskog and Schulte, 2013). We therefore decided to look deeper into the effect of 
WNT-5A on N13 cells. WNT-5A stimulation (300ng/ml) of N13 plasma membrane 
fractions lead to a profound 105% increase in [-35S]GTP incorporation compared to 
vehicle control (total incorporation 205 ± 27%) (fig.5A). This signal is comparable, or 
stronger, in magnitude to results obtained from endogenously expressed -opioid- and   
5-hydroxytryptamine1A (5-HT1A) receptors (Alper and Nelson, 1998; Traynor and 
Nahorski, 1995). In a related study (Halleskog et al., 2012), using primary microglia we 
observed a similar response, indicating that the WNT-5A activity on guanine 
nucleotide exchange is physiologically relevant (fig. 5B). 
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The strength of the signal in combination with the subsequent finding that the WNT-5A 
effect was abolished by PTX pretreatment, strongly implicated the involvement of one 
or more of the 5 different subtypes (Gi, Go, Gt, Ggust or Gz) in the Gi/o protein family. 
However, Gz could be excluded since this subtype is not ADP-ribosylated and inhibited 
by PTX. Using native, non-denaturing, immunoblotting analysis in combination with 
an antibody recognizing the GTP-bound conformation of Gi1-3 proteins, we could 
subsequently confirm that the WNT-5A stimulation, in presence of [-35S]GTP, in 
plasma membrane fractions and saponin permealized whole cells, indeed lead to the 
activation of Gi proteins. The specificity of the antibody towards Gi1-3 was established 
by the lack of antibody affinity towards overexpressed constitutively active (QL-
mutant) Gi/o family proteins in HEK293 cells. This result in combination with RT-
PCR analysis of the expression profile of Gi/o subtype proteins in N13 (fig. 4B) strongly 
indicated that the WNT-5A evoked guanine nucleotide exchange takes place at Gi2 or 
3. With the current data at hand, however, we cannot exclude the involvement of Gt 
proteins totally. Further genomic analysis of WNT receptors expressed in N13 revealed 
that these cells contain LRP5/6 co-receptors but, on the other hand, only produce trace 
amounts of ROR1/2 and RYK mRNA (Halleskog et al., 2011). Moreover, using QPCR 
we could determine the N13 FZD protein expression profile: 
FZD5>FZD7>>FZD2>FZD4=FZD9>FZD8 (fig. 4A). Consequently, since the expression 
of FZD5 was more than 3 times that of FZD7, we could surmise that WNT-5A signaling 
to Gi2/3 proteins, most likely, was transduced via the activation of FZD5. However, we 
could not obtain direct molecular and functional proof to support this notion. Even 
though FZD5 protein abundance readily could be detected by immunoblotting, co-
immunoprecipitation of FZD5 and Gi proteins was unsuccessful. Moreover, all 
attempts to genetically manipulate FZD5 expression in N13 failed. Interestingly, 
however, by SDS-PAGE analysis we could observe an electrophoretic mobility 
retardation shift of FZD5 after WNT-5A stimulation. Similar shift has previously been 
described at e.g. β2ARs as a result of receptor phosphorylation following agonist 
Figure 5. [-35S]GTP assay in plasma membrane fractions from N13 (A) 
and primary microglia (B). Plasma membranes were incubated with 
either control solution or 300ng/ml WNT-5A. Error bars provide SEM.  
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activation (Stadel et al., 1982). Of further interest was also the fact that a goat-anti-
FZD5 antibody (from R&D systems) only could recognize the receptor when a post 
WNT-5A-stimulation epitope was exposed by FZD5. Perhaps, although not specified 
by the producer, this FZD5 antibody is only able to detect phosphorylated receptor 
proteins. 
 
In conclusion, we show in this study that WNT-5A is a direct activator of Gi2/3 proteins 
in cells expressing FZD5 as the main WNT receptor. This is the first study using 
endogenous protein levels to detect the WNT-induced activation of G protein signaling. 
 
4.1.2 Analysis of differential signaling by WNT isoforms in N13 cells 
(paper II) 
In the second article we report that WNT signaling is differential in activity and 
pathway specificity with regard to a specific WNT isoform. The WNT signaling 
network holds important pharmacological potentials, however, in order to go further 
with WNT drug development, a thorough characterization of the specificities in 
receptor binding and consequent downstream events needs to be performed. Thus, we 
were curious to investigate how different WNT isoforms would initiate signaling in 
N13 cells. Since we already had established the WNT receptor profile of these cells, we 
could draw interesting conclusions with regard to beta-catenin-dependent and -
independent signaling features of the different WNTs. 6 different commercially 
available (from R&D systems) recombinant WNTs; -3A, -4, -5A, -5B, -7A, -9B, were 
assayed using: [-35S]GTP assay for G protein activation, immunoblotting detection of 
i) beta-catenin stabilization, ii) phosphorylation of LRP6 and iii) DVL electrophoretic 
mobility shift, and MTT-assay for cell proliferation (table 2).  
 
Interestingly, the only isoform truly capable of beta-catenin-dependent signaling was 
WNT-3A which showed strong phosphorylation of LRP6, stabilization of beta-catenin 
and activation of DVL3. Although all WNTs tested did show activity in inducing 
guanine nucleotide exchange, only WNTs -5A and -9B were able to induce significant 
increases in proliferation. This result also correlated to the efficacy of G protein 
activation as WNT-5A and -9B were able to induce [-35S]GTP incorporation at 49 and 
40%, respectively, above control level. The fact that activity in the [-35S]GTP assay 
was observed for all the WNTs, even for the -7A isoform which performed poorly in all 
other experimental methods used, prompted us to test of the purity of the WNT 
preparations, although endotoxin levels were reported very low. To make sure that no 
WNT unrelated activities by contaminants were responsible for the results obtained (as 
shown by Cajanek et al in 2010 (Cajanek et al., 2010)), we performed WNT signal 
blocking by SFRP-1 sequestering. The pre-incubation of SFRP-1 with WNT isoforms 
successfully blocked all downstream PS-DVL3 formation, except in the case of WNT-
9B. However, both WNT-5A- and -9B-induced proliferation was abolished by the 
presence of SFRP-1. With these results in hand, we could conclude that the observed 
effects were WNT-related. Studies have previously shown that combinatorial 
stimulation with WNT-3A and -5A could lower the -3A-induced beta-catenin 
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dependent signaling response by competition on LRP6 or FZD2 or by ROR-related 
signaling transduction (Bryja et al., 2007c; Mikels and Nusse, 2006; Topol et al., 2003). 
Since we had established that FZD2 and ROR1/2 mRNA levels were low in N13 and 
that ROR1 protein expression was hardly detectable in these cells, we expected to find 
no effect of WNT-5A on -3A-induced beta-catenin stabilization. As hypothesized, no 
reductions in P-LRP6 or beta-catenin levels were observed when adding increasing 
concentrations of WNT-5A to WNT-3A stimulated cells. However, there seemed to be 
an additive effect on the formation of PS-DVL3 induced by the combination of WNT-
3A and -5A stimulation. For each of the WNTs investigated in this article, several 
different FZDs have been reported as binding partners. FZD5, being the most abundant 
WNT receptor in N13, is of course interesting to consider as the primary target of WNT 
signaling transduction. WNTs -5A, -7A and -9B have been reported to interact with and 
induce signaling via FZD5 but perhaps, due to the lack of ROR1/2 and RYK co-
receptors, more of the WNT isoforms are able to communicate via FZD5. Of the other 
FZD proteins present in N13, FZD2 and FZD9 were reported to be associated to WNT-4 
and -7A signaling respectively.  
 
 
 
 
 
 
 
 
 
The potential in using an immortalized cell line as a read-out system for physiological 
responses is of course limited. However, the results shown in this study, somewhat 
correlates with WNT-induced proinflammatory responses observed in primary 
microglia cultures (Halleskog et al., 2012; Halleskog et al., 2011; Halleskog and 
Schulte, 2013). Moreover, all of the WNTs tested, except WNT-3A, are expressed in 
the healthy adult brain, indicating an important role of these signaling molecules in 
maintaining and regulating normal neuro-pathophysiological processes. 
 
 
Table 2. Summary of the properties and activities of the WNTs used in the study. Preparations are 
commercially available from R&D systems and column 2 provides the catalogue number. The 
WNT’s capacity to transform C57MG cells and their expression in the brain was summarized from 
the literature (for references, see paper II). Data is described by:  -, no activation/expression; +, 
weak activation/expression; ++, intermediate activation/expression; +++, strong activation/expression. 
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4.2 CHARACTERIZATION OF DYSFUNCTIONAL WNT/FZD SIGNALING 
IN MUTATED FZD6 PROTEINS (PAPER III)  
The role of WNT/FZD signaling pathways in organism development has been 
appreciated since the early days of their discovery. Moreover, mutations in either the 
ligands or the receptors are often found to cause lethality in embryonic stages. Perhaps, 
due to the severe effects of mutations in WNT signaling-related genes, only very few 
pathogenic mutations have been found in human FZD genes, e.g. mutated FZD4 protein 
can be directly linked to the development of familial exudative 
vitreoretinopathy/advanced retinopathy of prematurity. In the third article we identify 
and investigate two novel pathogenic mutations in the human FZD6 gene giving rise to 
autosomal recessive nail dysplasia.  
 
Proper nail development involves the communication and interaction between 
mesenchymal cells of the nail plate and epidermal cells of the nail bed. Phenotypic 
evaluation of individuals suffering from nail dysplasia indicated that the disease was 
caused by improper formation and attachment of the nail plate. Moreover, analysis of 
nail development in mice FZD6/FZD3 double mutants reveled perturbed nail 
development in 50% of the male animals and investigation of FZD6 expression during 
embryonic development showed a transient FZD6 mRNA expression peak at E14.5 in 
epidermal cells of digital tips. The results thus establish that FZD6 is expressed in the 
developing nail and important for the formation of the nail bed.  
 
Further genetic evaluation of four individuals in each of two different families (F1 and 
F2) suffering from autosomal recessive nail dysplasia were shown to be homozygous 
for a nonsense mutation (c.1750G>T; p.E584X) and a missense mutation (c.1531C>T; 
p.R511C) respectively. Notably, the individuals in F2, carrying the missense mutations, 
showed a more severe disease phenotype than the members of F1. Primary fibroblasts 
from disease affected F1-individuals revealed that the nonsense mutation lead to 
improper protein expression; only 13% mRNA was found in these cells compared to 
wild-type (WT) fibroblasts. Further, plasmid DNA transfection in HEK293 with the 
nonsense mutated FZD6 gene did not result in any protein product. Therefore, only the 
missense FZD6-R511C mutant was analyzed with regard to subcellular localization. 
However, since primary fibroblasts only were obtained from F1 members, downstream 
WNT-beta-catenin-dependent and –independent signaling potentials were analyzed in 
these cells. WNT-3A and WNT-5A stimulation of the F1-primary fibroblasts revealed 
absence of -catenin stabilization and no increased expression of DKK1 or the 
transcription factor MSX1 respectively. WNT/-catenin-dependent and –independent 
signaling pathways were thus shown to be impaired in primary fibroblasts lacking the 
FZD6 protein. Moreover, we here demonstrate that FZD6 is able to mediate -catenin 
stabilization, an interesting result regarding the fact that FZD6 is considered as a 
PCP/CE-signaling transducer and shown to affect -catenin signaling in an antagonistic 
manner (Golan et al., 2004).  
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Analysis of subcellular localization of missense-mutated FZD6 proteins expressed in 
HEK293 revealed that the receptor was confined to intracellular vesicular 
compartments to a much greater degree than WT FZD6 (fig. 6). Thus we could observe 
that the missense mutation caused FZD6 to display improper plasma membrane 
localization. We then investigated the nature of the vesicles containing FZD6 R511C 
and our results clearly showed that the consequence of the missense mutation further 
caused the receptor to be trapped in lysosomal compartments. However, we were 
unable to determine the events leading to this outcome, i.e. if FZD6 R511C proteins are 
inserted but removed from the plasma membrane more extensively than WT receptors, 
or if the missense mutants trapped in lysosomes never were inserted in the membrane.  
 
 
 
 
 
Interestingly, the R511C point mutation is situated 7 amino acids downstream of the 
KTCTE PDZ-lignad domain and could therefore have an impact on the interaction of 
FZD6 with DVL proteins. We examined the ability of the FZD6 R511C to associate 
with DVL1 using immunocytochemical evaluation of FZD-mediated membrane 
recruitment of DVL, as well as measuring acceptor photobleaching FRET between 
GFP-fused FZD6 proteins and Cy3-antibody tagged DVL1. Our results showed that 
despite the proximity of the mutation to the PDZ-ligand domain, FZD6 R511C was still 
able to associate with DVL1, albeit not as efficient as FZD6wt. This further suggests 
that additional regions of FZD6, other than the KTCTEW, might contribute to biding to 
DVL1, much like the interaction between FZD5 and DVL1. Also, the fact that FZD6 
R511C can associate with DVL1 opens up the possibility that missense-mutated 
receptors at the plasma membrane still could mediate signaling. Collectively, our 
results suggest that loss of FZD6 protein and consequent WNT/FZD6 signaling is 
causing the nail dysplasia phenotype. The fact that F2 individuals with missense-
mutated FZD6 shows a more severe phenotype than nonsense-FZD6-carrying F1 
members do, moreover suggests that additional disturbances in signaling created by an 
impaired but still present receptor might contribute to further negative effects in the 
WNT-regulated process of nail tissue maintenance.   
Figure 6. Subcellular localization of WT FZD6 and FZD6-R511C. (A) Represenative pictures of the 
different receptor localization patterns observed. (B) Quantification of localization patterns.The mean 
values ± standard deviation (SD) were 70.7 ± 2.8 (FZD6[wt]membr); 14.3 ± 2.4 (FZD6  
[missense]membr), 15.5 ± 1.3 (FZD6[wt]membr to vesic), 22.5 ± 2.6 (FZD6[missense]membr to 
vesic), 13.8 ± 1.5 (FZD6[wt]vesic),and 63.2 ± 1.4 (FZD6[missense]vesic). 
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4.3 FRAP-BASED ASSESSMENTS OF FZD6 SIGNALING PROPERTIES 
In order to further investigate WNT signaling events at the receptor level we decided to 
employ a live-cell imaging approach; i.e. Fluorescence Recovery After Photobleaching 
(FRAP). This technique has been used to successfully establish e.g.  the 
oligomerization of 2ARs, the dynamic compartmentalization of neurokinin- and μ-
opioid receptors and the association of G proteins with 5-HT1A receptors (Cezanne et 
al., 2004; Dorsch et al., 2009; Pucadyil et al., 2004; Sauliere-Nzeh Ndong et al., 2010). 
Thus in the fourth and the fifth article we introduce and establish FRAP-based 
techniques as novel tools to assay WNT actions on defined FZD protein molecules and 
intracellular effectors.   
 
4.3.1 Analysis of WNT isoform-specific effects on FZD6 lateral mobility 
(paper IV) 
In article four mono-color fluorophore FRAP was performed to assess WNT 
stimulation-induced changes in FZD6-EGFP protein lateral diffusion in HEK293 
plasma membranes. Surprisingly, WNT stimulation did not lead to retardation in 
receptor mobility, rather, after 15 minutes of WNT-5A incubation FZD6 rate of 
diffusion was significantly increased as observed by the elevation of the fluorescence 
recovery curve plateau. Control experiment using NECA-induced elevation of 
adenosine 1 receptors (A1R) mobility confirmed that the result was not caused by the 
association-dissociation of ligand to-from the receptor since the molecular size of 
NECA is much smaller than that of WNT-5A. We therefore began to suspect the 
involvement of intracellular effector molecules. Overnight pretreatment with PTX as a 
means to uncouple/inhibit Gi/o protein–receptor association resulted in up-shifted 
recovery curve plateaus, i.e. increased receptor mobility in the plasma membrane. This 
outcome highly resembled the WNT-5A stimulation-induced behavior of the FZD6. 
Moreover, PTX pretreatment effectively abolished any further WNT-5A-promoted 
increase in receptor mobility. Collectively, these results strongly pointed to the 
participation of heterotrimeric Gi/o proteins in the WNT-5A-evoked effect on FZD6. To 
further test this hypothesis, HEK293 was transfected with PTX resistant Gi2C352I 
mutant proteins and the subsequent discovery showed that in the presence of PTX, this 
action was sufficient for the recovery and re-establishment of FZD6 low basal mobility 
and sensitivity towards WNT-5A stimulation. Altogether, these results support the 
notions of: i) in the basal state FZD6 consists of a precoupled receptor-Gi protein 
complex, and ii) the complex dissociates upon WNT-5A stimulation ultimately leading 
to an elevation in lateral diffusion capacity of the receptor. Thus, the results provide 
evidence of a WNT/FZD/G protein interaction in living cells.  
 
In article three we showed that the FZD6-R511C protein, even though harboring a 
mutation in close proximity to the KTCTEW domain, still is able to interact with and 
recruit DVL to the plasma membrane. However, we did not look into the mutant 
receptor’s capacity to associate to G proteins.  As was concluded in the study, the 
individuals homozygous for the missense mutation displayed a more severe phenotype 
than the FZD6 nonsense mutated patients, indicating that, besides the lysosomal 
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compartmentalization, there might be additional pathogenic features of the missense 
mutation. In order to gain further knowledge regarding this notion, we subjected FZD6-
R511C-GFP transfected HEK293 cells to FRAP analysis. Interestingly, we found that 
the FZD6-R511C protein was non-responsive to WNT-5A stimulation with regard to 
increased lateral mobility effects. Moreover, pretreatment with PTX neither caused any 
increase in basal, non-stimulated, state mobility nor lead to any change in the 
insensitivity of the mutated receptor towards WNT-5A. Collectively, the results suggest 
that the missense mutant FZD6-R511C might be deficient in G protein coupling and 
consequently unable to relay WNT-induced activation of heterotrimeric G proteins, a 
cellular process which might otherwise be necessary for maintaining proper nail 
physiology. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. PTX-resistant mutant Gi2-C352I rescues agonist-induced effects on receptor lateral mobility 
in presence of PTX. (A) FZD6-GFP fluorescence recovery in HEK293 co-transfected with untagged 
Gi2-C352I at 0 and 15 min of agonist stimulation in absence (open bars) and in presence (hatched bars) 
of overnight PTX pretreatment. (B) Presentation of A1R-GFP mobile fractions using the same set up as 
in A.  
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In current pharmaceutical research there is an increasing interest in the concept of 
functional selectivity or signaling bias, not only mediated by drugs and synthetic 
ligands but also by endogenous agonists. For example, recent studies have revealed that 
the actions of endomorphins, on μ-opioid receptors seem to exhibit pathway-selective, 
biased, signal transduction (Rivero et al., 2012). In the second article we showed that 
WNTs might act on FZDs in a similar way to steer cell communication into different 
directions. To analyze this concept at the receptor level, we used the reductionistic 
FRAP approach to measure WNT-isoform-specific abilities in eliciting changes in 
FZD6 molecular mobility. 10 different recombinant WNTs (WNT-1, -2B, 3A, -4, -5A, -
5B, -7A, -9B, -10B and -11) were used and FZD6 mobility was measured at 0, 5, 15 
and 30 min of stimulation.  Interestingly, the sensitivity of the assay proved sufficient 
enough to detect differences among the WNTs. As was seen in article II, WNTs -3A 
and -4 showed similar efficacies and dynamics in evoking GDP/GTP exchange and 
again in the FRAP-assay these two WNTs produced similar time-dependent patterns in 
their FZD6 mobility induction activity. The result is a bit surprising since WNT-3A is 
classified as a -catenin dependent WNT while WNT-4 is performing mainly -catenin 
independent signaling. On the other hand, although both WNT-1 and WNT-3A are 
categorized as classical -catenin dependent signaling WNTs, their activation profiles 
in the present assay differs. While WNT-3A shows a slow and increasing effect on 
FZD6 diffusion, WNT-1 has a quicker and more transient effect indicating different 
abilities in receptor conformation stabilization. Moreover, the fact that these two -
catenin-dependent WNTs shows activity at FZD6 is interesting since FZD6 mainly is 
viewed as a mediator of PCP signaling and can act as a repressor of-catenin 
dependent WNT signaling. WNT-7A, which previously has been proven a binding 
partner for FZD6, shows a sharp, very transient action in changing receptor diffusion 
rate and a similar, but less efficient, result was obtained for WNT-2B. By analysis of 
gene expression in differentiated gut epithelial cells, FZD6 expression was found in 
close proximity to WNT-2B-producing cells in a region devoid of -catenin related 
signaling events (Gregorieff et al., 2005). These results indicate a rapid and transient 
FZD6 mobility change, perhaps connected to a -catenin-independent signaling 
pathway activated by WNT-2B.   The activities of WNT-5A and WNT-10B are similar 
in kinetics but the response maximum of WNT-10B is almost 10% stronger than WNT-
5A. Although both WNT-7A and WNT-10B seems to have the same abilities in total 
receptor binding, they appear to have different functions in stabilizing FZD6 
conformation; binding of WNT-7A results in the formation of a less stable agonist-
induced receptor conformation than the interaction of WNT-10B with FZD6 does. The 
FRAP-based measurements of WNT activity further showed that WNTs -5B and -11 
most likely are very weak agonists at FZD6, since no significant increase in FZD6 
mobility was observed when stimulating the receptor with these WNTs. WNT-9B 
activity also proved moderate in comparison to WNT-1, -5A, -7A and -10B, suggesting 
that WNT-9B, like WNTs -5B and -11, is a low affinity agonist at FZD6. Using the data 
at hand, four different groups can be distinguished: group I) fast and transient: WNT-
2B and WNT-7A; group II) intermediate and transient: WNT-1, WNT-5A, WNT-9B 
and WNT-10B; group III) slow and persistent: WNT-3A and WNT-4; and group IV) 
no/low activity: WNT-5B, (WNT-9B) and WNT-11 (fig. 8).  
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In conclusion, these results indicate that the WNTs tested have different affinities for 
FZD6 and upon binding are able to establish different receptor conformations with 
different stabilities over time. Also, the observed results could be dependent on 
different FZD-FZD homo/heterodimers as well as FZD-coreceptor complexes which 
differs in affinity for the tested WNTs and might have varying degrees of complex 
stability upon WNT stimulation. The observed isoform-specific activation patterns 
could further suggest that depending on the WNT binding, signaling will be relayed via 
different combinations of intracellular effectors which ultimately determine the 
nature/magnitude of FZD6 lateral diffusion in the plasma membrane.  However, it 
should be stressed that the FRAP-based evaluation of agonist-receptor activity only 
accounts for changes in FZD6 protein mobility and does not cover other possible 
outcomes of WNT signaling action. Therefore, further assays needs to be performed in 
order to fully understand how and which WNT-FZD6 interactions truly occur. 
 
 
4.3.2 Analysis of FZD6 signaling complex composition (paper V) 
In this study a dual fluorophores approach was used for FRAP analysis of the FZD6 
signaling complex. FZD6 fused to mCherry or GFP and G subunits tagged with either 
GFP (Gi1 and Gs), Venus (GoA and Gq), or mCherry (G12) were coexpressed in 
HEK293 in combination with untagged  subunits. FRAP measurements were 
obtained simultaneously for both fluorophore-fused proteins and receptor lateral 
mobility was modulated by employing extracellular surface Sulfo-NHS-LC-LC-biotin 
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Figure 8. Web diagram summarizing the efficacies of WNTs presented as changes in FZD6-GFP 
protein mobility over agonist stimulation time period.  Blue line: 0 min stimulation, red: 5 min, 
green: 15 min and purple: 30 min. WNT efficacies are normalized to the lowest and highest 
values.  Results based on at least 3 independent experiments per WNT. 
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and avidin mediated cross-linking. The NHS-group reacts with lysines and primary 
amines protruding from the outer leaflet and establishes a surface of covalently bound 
biotin moieties. The addition and binding of avidin to biotin creates a tight mesh of 
cross-linked molecules which immobilizes all proteins extending out from the cell 
surface. This modified FRAP approach has been used and validated for the analysis of 
receptor oligomerization, receptor-G protein precoupling and heterotrimeric G protein 
complex stability (Digby et al., 2006; Fonseca and Lambert, 2009; Lober et al., 2006; 
Qin et al., 2011; Qin et al., 2008). Here, we investigate precoupling of FZD6 to different 
G subunits representing the four G protein families: Gs, Gq/11, Gi/o andG12/13. 
Additionally, using the modified dual color FRAP technique, the interaction of DVL 
with FZD6 was examined as well as the role of DVL in the process of FZD6-G protein 
assembly.  
 
Analysis of protein localization, determined by immunocytochemistry, placed FZD6, 
Gi1 and DVL at the plasma membrane. Thus, even though G proteins are 
overexpressed, FZD6 is still able to recruit DVL, indicating a possible molecular 
interaction and assembly consisting of FZD6, G proteins and DVL. Using cell surface 
cross-linking and dual color FRAP we found that FZD6 was precoupled to Gi1 and Gq 
with about 20% of the total pool of tagged G subunits, but unable to form a stable 
complex with GoA, Gs and G12 (fig. 9). The interaction of FZD6 with either Gi1 or 
Gq was further confirmed by acceptor photobleaching FRET between FZD6-mCherry 
and Venus-tagged G. Gi1-FZD6 precoupling was also shown to be PTX-sensitive, a 
result which agrees with the data observed in paper IV. The effect of PTX on receptor-
G protein precoupling is indicative of constitutive activity, since PTX only is able to 
ribosylate the Cys moiety at G subunits during the phase of nucleotide exchange. The 
results thus suggest that FZD6 has constitutive activity or perhaps that endogenous 
auto/paracrine WNT stimulation in the cell culture will activate FZD6. Since PTX 
treatment is performed overnight, both scenarios provide a plausible explanation for the 
observed complete abolishment of Gi1-FZD6 precoupling in the presence of PTX. 
Next, the precoupling of FZD6 to Gi1/q was investigated in the presence of WNT-5A.  
Results showed that the interaction between FZD6 and Gq was dynamic since 
coupling was lost after 5 minutes of WNT-5A stimulation but reestablished again after 
15 min. The dissociation of Gi1 proteins from FZD6 was somewhat more persistent, or 
perhaps slower, since no pbFRET or FRAP-measured mobility retardation could be 
observed after 15 min of WNT-5A stimulation. Compared to conventional G protein 
activation and dissociation kinetics, the presently observed WNT-5A-induced 
dissociation of Gi1 is rather slow. However, lack of dissociation in the early steps of 
activation is a known feature of Gi1 proteins (Gales et al., 2006) and thus could 
contribute to the observed results. In conclusion, these results show that FZD6 
selectively precouples to Gi1 and Gq heterotrimeric G subunits and that WNT-5A is 
able to evoke signaling at FZD6 leading to the uncoupling of G proteins from the 
receptor. Interestingly, our FRAP analysis also revealed that the FZD6-R511C mutant is 
not able to form stable receptor-G protein complexes, consolidating and confirming the 
results obtained in paper IV. The result provides further indication that aberrant WNT-
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G protein signaling might be an important factor in the development of the nail 
dysplasia phenotype.  
 
 
 
 
The R511C point mutation is located eight amino acids from the PDZ-ligand domain in 
the C-terminal direction and in a part resembling a basic region conserved in several 
Class A 7TM receptors. The presence of an additional Cys in this particular region 
might cause distortions in secondary and tertiary structures required for G protein 
coupling at FZDs.   The direct molecular interaction of FZD with DVL has been 
studied intensely and current results using peptide interaction scanning methods shows 
that apart from the PDZ-ligand domain in the ICD, DVL-DEP domain also engages a 
discontinuous motif in ICL3 for interaction with FZDs. Moreover, DVL membrane 
localization is stabilized by pH-dependent electrochemical interactions between 
positively charged moieties in the DVL C-term and negative charges on membranous 
acidic lipid molecules. Interaction with electronegative plasma membrane was also 
found to be a requirement of M3R-Gq preassembly, showing that localization patterns 
of both G proteins and DVL are sensitive to changes in pH. Despite the well-
established fact that molecular interaction between FZDs and DVL exists, the 
interaction is difficult to quantify. For example, pull down of FZD and mass 
spectrometric analysis of FZD-associated proteins have so far been unsuccessful in 
detecting DVL. Thus, in the present study, we used the dcFRAP technique to 
circumvent disruption of the native cellular milieu. Biotin-avidin-mediated 
immobilization of FZD6-mCherry in HEK293 cells coexpressed with DVL2-GFP 
Figure 9. FZD6 differentially couples to members 
of the heterotrimeric G protein family.  Using 
dcFRAP analysis we investigated the effect of 
surface cross-linking on mobility of Gαi1-GFP (A), 
Gαq -Venus (B), GαoA -Venus (C), Gα12 -mCherry 
(D), Gαs –GFP (E). Receptor models visualize the 
experimental set-up. 
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revealed that approximately 40% of fluorescently tagged DVL molecules are affected 
by the cross-linking of FZD6, thus indicating a strong association between these two 
proteins. Further, our FRAP data showed that the FZD6-R511C protein retains the 
ability to interact with DVL, an interesting result with regard to the close proximity of 
the Arg to Cys mutation to the KTCTEW domain of FZD6. The fact that the mutated 
receptor is unable to couple to G proteins, but on the other hand can associate to DVL 
raises the question of whether it is the disturbance in the balance between different 
signaling branches or the total impairment of signaling ability due to the loss of a 
crucial signaling component that ultimately results in a diseased phenotype. Moreover, 
with the present data at hand the redundancy in the requirement of specific protein-
protein interaction domains at DVL and FZDs can be questioned. Computational 
predictions and biochemical experiments have identified the FZD region which 
interacts with G proteins and DVL. The intriguing fact that these interaction sites 
virtually are overlapping pushed us to investigate the role of DVL in the FZD6-Gi1 
and FZD6-Gq protein interactions. A few models of the FZD-DVL-G protein 
molecular interplay have been postulated, such as e.g. a DVL-G protein competition 
model; a DVL-G protein temporal model (of fast G protein signaling and slow DVL 
communication) and a DVL-G protein compartment model (G proteins and DVL 
resides in different regions/receptors at the plasma membrane). According to or 
dcFRAP results either panDVL RNAi silencing or overexpression of DVL1-3 caused 
severe impairment of G protein coupling, indicating a crucial role of DVL in the FZD-
G protein precoupling process. Not only was DVL found to be required but, moreover, 
the balance of DVL protein concentration is an essential factor (fig. 10). Such a 
molecular relationship has not been described earlier and might explain the difficulty in 
observing WNT/G protein signaling when working with DVL-overexpression systems. 
Control experiment using the cannabinoid 1 receptor (CB1R)-Gi1 precoupling pair 
confirmed that the DVL effect indeed was receptor-specific for FZD6. The DVL protein 
contains three distinct domains: the N-terminal DIX domain involved in DVL (or Axin) 
oligomerization; the PDZ domain interacting with the FZD KTxxxW region; and the C-
terminal DEP domain responsible for plasmamembrane and FZD-ICL3 engagement. 
Previous studies have shown a possible interaction between the DVL-DEP domain and 
the G complex perhaps suggesting a role for DVL as an AGS class III signaling 
factor. We thus investigated the requirement of the different DVL domains in the 
stability of the FZD-G protein complex. Using DVL3 deletion mutants we observed 
impaired FZD6-Gi1/Gq precoupling only in the experiments with DIX domain-
containing mutants. This result is interesting since the DIX domain, thus far, mainly has 
been implicated in -catenin dependent pathways where DVL oligomerization was 
found to be required for proper signaling. Moreover, since the DIX domain was found 
dispensable for FZD5-DVL1 interaction, the DIX-mediated effects on FZD6-Gi/q 
precoupling is probably not reliant on direct receptor binding. On the other hand we can 
see a clear membrane recruitment of DVL3-DIX mutant in the presence of 
overexpressed FZD6.    Alternatively, the overexpression of DIX domains capable of 
protein multimerization might generate an intracellular mesh of DIX domain-
endogenous DVL molecules at the plasmamembrane, thereby creating distortions in the 
spatial requirements for FZD6-G protein precoupling. The DIX domain is also shown to 
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mediate LRP6 clustering via activation and interaction with PIP5K. Induced clustering 
of LRP6 could potentially disturb FZD6 complex arrangement and G protein 
precoupling. Yet, in order to fully understand the role of DVL and the DIX domain in 
FZD6-G protein interactions more studies need to be performed analyzing 
stoichiometry and dynamics between the molecules. 
 
 
 
 
 
 
In order to establish the functional outcome of DVL concentration-dependent FZD6-G 
protein coupling we measured WNT-5A-induced ERK1/2 activation. Even though 
precoupling was perturbed at low/high DVL levels, the collision coupling mode of 
GPCR-G protein interaction and activation might be functional. However, as we could 
deduce from our results, cell subjected to either PTX treatment, DVL RNAi silencing 
or DVL1 overexpression did not induce ERK1/2 phosphorylation when stimulated with 
WNT-5A. Collectively, the results show that precoupling of receptors and G proteins, 
rather than collision coupling, is the limiting factor in signaling transduction at FZD6.                     
 
Figure 10.  FZD6-Gi1/Gq precoupling is affected by changes in DVL protein levels. 
Receptor-G protein coupling efficiencies were evaluated using dcFRAP analysis of cells 
with high DVL concentration (cotransfected with DVL3-FLAG), endogenous 
concentration (no cotransfection) and low concentration (pan DVL siRNA transfection).  
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5 GENERAL DISCUSSION 
WNT signaling governs important processes throughout the lifespan of metazoans, 
such as embryonic development and tissue homeostasis and its role in human disease is 
now well established. Thus the WNT signaling system holds valuable therapeutic 
potentials. Moreover, FZDs belong to the GPCR protein superfamily and the 7TM 
receptors are the most common targets of drugs today on the market. Developing 
compounds to target specific levels of and events in the WNT signaling pathways 
would be desirable. However, the study of WNT/FZD signaling pharmacology is 
cumbersome to perform due to several factors: 
i) Agonist complexity - the WNT proteins are complex molecules with high 
degree of hydrophobicity and unspecific interactions with the ECM. Hence, 
in a physiological context, the concentrations at which WNTs exert their 
activities are difficult to deduce. Additionally, owing acylations and 
glycosylations, WNTs are difficult to purify and isolate in active and 
functional form. Typically, in a given preparation of recombinant WNT there 
is currently no possibility of knowing the exact concentration of active WNT. 
Thus, measurements of affinity, efficacy and potency using endogenous WNT 
proteins at the cognate receptors are not possible to conduct at this stage.  
ii) Receptor complexity – the diversity of WNT signal activation at the 
plasmamembrane is a fact: currently 15 different proteins have been 
identified as receptors or co-receptors in WNTs signaling pathways. Since 
experimental results indicate that various combinations of WNT receptors/co-
receptors are able to respond to a specific WNT isoform, the receptor profile 
of the cell/tissue under investigation must be established in order to deduce 
which components to target. Additionally, transmembrane proteins are 
difficult to isolate in their native and active state and thus the investigation of 
WNT to receptor signal transduction is a slow process. Knowledge 
concerning which pairs of receptors and co-receptors are needed for WNT 
activation is indeed limited.  
iii) FZDs are unconventional GPCRs – despite the 7TM receptor structure, 
conserved and essential G protein-binding motifs present in Class A receptors 
are lacking in FZDs. Attempts to obtain FZD crystal structures or isolated 
FZD proteins has so far been unsuccessful. Moreover, G protein activation 
downstream of FZDs can happen in non-classical manners, such as Go-
mediated -catenin signaling, in which DVL and Axin participate in G protein 
interaction. Assessment of FZD isoform-specific activities is a cumbersome 
process since the vast majority of known cell types endogenously express 
several FZD isoforms. 
Considering the above factors, it is clear that current and common pharmacological 
methods and tools, in most cases cannot be employed. The study of WNT/FZD/G 
protein signaling requires the use and development of alternative approaches. In the 
work comprising this thesis both classical methods, such as [-35S]GTP assay, as well 
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as novel techniques, e.g. dcFRAP and receptor immobilization, were utilized in order 
to gain new knowledge into the properties of FZD signal transduction. 
  
As mentioned earlier, the notion of the receptors of Class F being bona fide GPCRs 
have been the source of a long-standing debate within the WNT field even though 
sound and compelling data strongly pointed out the connection between FZDs and G 
proteins (Ahumada et al., 2002; Liu et al., 2001; Liu et al., 1999; Sheldahl et al., 1999; 
Slusarski et al., 1997a). Recent work of other research groups as well as the results 
presented in this study, further provides direct evidence of WNT-induced and FZD-
mediated G protein signaling, thus confirming previous observations and establishing 
FZDs as true GPCRs. It is, however, evident that FZD signal transduction is different 
compared to the conventional pattern of signaling outlined for Class A 7TMRs. The 
recently solved SMO crystal structure suggests that, even though the motifs essential 
for G protein signaling in Class A receptors are missing, alternative primary and 
secondary structures can compensate to mediate G protein interaction. Thus, we begin 
to realize that the structure-function features of GPCRs are much more diverse than 
was previously thought. FZDs, as stated earlier, have unique surfaces for protein 
interaction. The intracellular part contains specific motifs shown to interact with DVL 
and these sites overlap with the predicted points of G protein contact. Our present 
results show that Gi2/3 signaling, presumably via FZD5, is disturbed by the presence 
of DVL as observed by “contaminated” plasma membrane fractions and by the 
addition of recombinant DVL (fig.11). Since it was shown that FZD5 engages DVL by 
motifs in the third ICL as well as by the C-terminal KTxxxW, it is reasonable to 
suggest that competition between DVL and Gi for the interaction with FZD5 exist. 
However, this model might not be true for other FZD isoforms. E.g. FZD6 and FZD3 
lack the DVL1-DEP-C domain-binding motif I in the ICL3 which is otherwise 
conserved among Class F receptors. Thus, it was postulated that the loss of motif I in 
FZD6 and 3 could result in weakened binding or alterations the position of DVL at 
these receptors. Since FZD6 and FZD3 both are strongly connected with PCP/CE 
signaling, this less rigid DVL interaction might favor -catenin-independent signaling 
over the -catenin-dependent pathway. Moreover, a flexible binding of DVL to FZD, 
as seems to be the case of FZD6, could perhaps allow simultaneous DVL and G protein 
binding. In the light of our finding that DVL presence is needed, albeit only at an 
endogenous concentration, in order for FZD6-Gi/q precoupling to occur, it can be 
concluded that different FZD isoforms might employ dissimilar models of DVL/G-
protein signal transduction. Applying the previously postulated models of FZD-G 
protein-DVL signaling mechanisms, one can speculate that FZD5 belongs to a category 
of FZDs which employs a DVL-G protein competition type of signaling model, while 
FZD6 might form DVL-G protein signalosomes in which the binding of DVL will 
confer a stabilizing effect on FZD-G protein precoupling. Consequently, the results 
could be indicative of a compartment model of FZD6 signaling complex assembly, i.e. 
dimers of FZD6 are formed in which one receptor couples to G proteins and the other 
to DVL. Functional signaling and G protein precoupling would then be dependent on 
an intracellular and DVL-mediated dimerization of FZD receptors. In order to confirm 
this notion, more information regarding the molecular stoichiometry of the involved 
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proteins needs to be gathered. Interestingly, the fact that the FZD6-R511C mutant can 
interact with DVL but is deficient in G protein precoupling could further suggest that 
Gi/q proteins preferentially engages FZD6 at the C-terminal helix VIII, while DVL 
association mainly is connected to motif II in ICL3.  
 
 
 
Current data dictates a preponderant role of Gi/o in WNT/FZD signaling. However, in 
accordance with in silico prediction of FZD-G protein interactions, we also observe 
Gq precoupling at FZD6. The kinetics of heterotrimeric G protein complex 
dissociation has been reported to occur faster at Gq complexes than at Gi, and if 
this is the case at FZD6 proteins, it could provide an interesting feature to investigate in 
respect to WNT functional selectivity. Considering WNT isoform-specific abilities in 
FZD6 mobility induction, it could be postulated that fast performing WNTs (i.e. WNT-
2B and WNT-7A) might favor Gq activation over Gi. The connection between Gq 
and WNT-7A could further be established by the fact that Gq activation readily is 
linked to -catenin signaling, which also is the pathway typically induced by WNT-
7A. However, the finding that Go proteins are activated downstream of WNT-7A-
induced FZD6 signal transduction when FZDs are ectopically expressed in  E. coli, 
points out the demand for additional data in order to understand the nature of WNT 
isoform-specific G protein subtype bias.  
 
In the concept of biased agonism, receptor phosphorylation patterns by GRK activity at 
intracellular regions seem to play an important part in dictating pathway preference, 
especially with regard to -arrestin functional activity (Liggett, 2011; Nobles et al., 
2011). It was found that upon agonist stimulation 2-adrenergic receptors (2AR) were 
targeted by GRK2 or GRK6 to induce changes in -arrestin conformation leading to 
either receptor internalization or ERK1/2 activation respectively. The phosphorylation 
pattern or barcode seems dependent on the nature of the ligand since it was shown that 
-arrestin biased ligands induced distinctly different phospho-barcoding of 2ARs 
compared to unbiased agonists (Nobles et al., 2011). Moreover the type of GRK also 
dictates the magnitude and duration of receptor--arrestin interaction. The receptor 
phosphorylation-related mechanisms of biased ligand hold important pharmacological 
properties and are currently under intense investigation, albeit primarily for class A 
7TMRs. Analyzing phosphorylation barcodes in the unconventional mode of 
Figure 11. WNT-5A induced incorporation of 
[-35S]GTP  in N13 plasma membrane 
fractions is blocked by the addition of 
recombinant  DVL. 
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WNT/FZD-induced and DVL-dependent signaling to -arrestins and G-proteins would 
be highly interesting. Since FZD internalization seems ligand- as well as FZD-subtype-
dependent, e.g. WNT-5A induces FZD4 internalization while endocytosis of FZD6 
never was observed regardless of the WNT used, it would be valuable to investigate 
how FZDs interact with specific GRKs. Moreover, will a specific FZD 
phosphorylation pattern affect DVL conformation and functional activity in the same 
way that 2-AR phosphor-barcode directs -arrestin signaling?                   
 
 
 
 
 
 
 
Collectively, the current data investigating signal transduction at FZD proteins clearly 
describes the presence of a mechanistic interplay between FZDs, G proteins and DVL, 
and further that the relationship is dynamic in response to WNT-stimulation. 
Therefore, we propose that a quaternary complex model (fig. 12) of FZD signal 
transduction should be used as a platform for future investigation of WNT signaling 
kinetics, affinities and efficacies, and by extension in order to establish the mechanisms 
of biased agonism in the WNT/FZD signaling system.               
 
Figure 12. Hypothetical quaternary complex model representing the different states of FZD: R 
activation and molecular interactions with WNTs: A, G proteins: G and DVL: D. Dimerization 
states have been omitted. Illustration by J. Petersen. 
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6 SUMMARY & CONCULSIONS 
 
Paper I 
WNT-5A mediated signal trafficking leads to GDP to GTP exchange at the G subunit 
of PTX-sensitive heterotrimeric Gi proteins in microglia-like cells at endogenous 
protein stoichiometry.  
 
Receptor/G protein repertoire in N13, as assessed by PCR, marks FZD5-Gi2/3 as the 
signaling components most likely responsible for transducing the WNT-5A effect. 
 
PaperII 
Assessment of WNT signaling profiles of 6 different recombinant WNTs using N13, a 
defined cell type with a unique set up of WNT-signaling components, as a readout 
platform reveals isoform-specific signaling features: 
-Only WNT-3A was able to signal in -catenin dependent manner. 
-All WNTs activated G proteins; however the WNTs most efficacious in G 
protein activation (-5A and -9B) also caused cell proliferation. 
-All WNTs tested caused phosphorylation of DVL, showing the central 
importance of this protein in WNT-mediated cellular signaling. 
 
Taken together, these results suggest that WNTs could act as endogenous biased 
agonists modulating cellular responses according to the respective ability of the 
isoforms to favor a specific subset of signaling components.    
 
PaperIII 
Two mutations in FZD6, E581X and R511C, were found to be pathogenic and 
responsible for the isolated autosomal-recessive nail dysplasia disease phenotype.  
 
The FZD6 mutant receptors were deficient in -catenin-dependent and –independent 
signaling but retained the ability to recruit DVL despite the proximity of the R511C 
missense mutation to the PDZ-ligand domain.        
 
The aberrant WNT signaling is most likely a consequence of the severely disturbed 
subcellular distribution pattern. Compared to wild-type FZD6, the R511C mutant shows 
strong tendency to be confined to lysosomal vesicular compartments. 
 
PaperIV 
Using FRAP to monitor FZD6-GFP lateral diffusion, we were able to detect direct 
WNT-induced effects on the mobility of the receptor protein. Thus, we establish a 
novel approach to investigate proximal WNT-signaling events. 
 
FRAP assessment revealed that receptor mobility was increased upon WNT-5A 
stimulation. The effect was PTX-sensitive but could be rescued by expression of the 
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Gi2C352I PTX-resistant mutant. Collectively, results suggest the involvement of Gi/o 
proteins in the WNT-5A-induced FZD6 mobility change. 
 
FRAP-based FZD6 mobility analysis also exposed WNT isoform-specific abilities in 
receptor mobility induction, showing that the assay is sensitive enough to detect 
differential signaling patterns of WNTs. 
 
PaperV 
FRAP analysis using a dual fluorophores- and cell surface cross-linking-approach 
reveals specificity in FZD6 precoupling to heterotrimeric G proteins. Gi and Gq were 
precoupled but not Go, Gs and G12. 
 
WNT-5A stimulation as well as PTX-pretreatment effectively causes dissociation of 
the FZD6-Gi complexes. WNT-5A stimulation also leads to dynamic changes in FZD6-
Gq molecular complexes. 
 
Both the wild type FZD6 and the FZD6-R511C mutant show strong DVL interaction, 
but the missense mutated receptor is deficient in G protein precoupling.  
 
DVL is a master regulator of FZD-G protein coupling since both RNAi silencing and 
DNA plasmid overexpression of DVL severely disrupts the G protein-FZD6 interaction. 
Thus, there is a fine-tuned mechanistic relationship between FZD/G protein- and 
FZD/DVL-signaling.  
 
Thesis conclusion 
Collectively, the work of this thesis shows that WNTs activate heterotrimeric G 
proteins both in overexpression systems and under native conditions. Further, it 
establishes FZD as the intermediate signaling molecule responsible for relaying WNT 
signals to G proteins. Moreover, the studies comprising this thesis point to a novel 
model of mechanistic relationship between 7TMRs and G proteins in which the 
precoupling complex is reliant on the local concentrations of a third party molecular 
component. Thus, with the present data at hand a quartenary complex model, consisting 
of WNT-FZD-G protein-DVL, is purposed in order to explain the interactions 
observed. However, the presence of a FZD dimer within this complex can also be 
suggested. This thesis work additionally shows the possibility of biased agonism in the 
WNT signaling system, a property which holds great opportunities in the pursuit to 
develop new drugs to target human disease.     
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7 POPULÄRVETENSKAPLIG SAMMANFATTNING 
Cell till cell kommunikation, även kallad cellulär signalering, är grunden till allt 
multicelluärt liv och bygger på tre huvudsakliga steg. Steg ett: en meddelande- eller 
signalmolekyl, t ex ett hormon eller en neurotransmittor, utsöndras från en cell för att 
sedan påverka samma cell och/eller andra celler runt om i kroppen. Steg två: vid cellens 
yta interagerar signalmolekylen med en mottagarmolekyl som sitter inbäddad över 
cellens hölje, det s k plasmamembranet. Mottagarmolekylen, vilken kallas receptor, 
översätter signalmolekylens meddelande och i och med detta kan nästa steg initieras. 
Steg tre: receptorn för vidare meddelandet genom att aktivera verkställande 
effektormolekyler inuti cellen vilket ofta leder till förändringar i cellens mognad eller 
funktion, till celldelning eller cellvandring, samt även ibland till celldöd. 
Farmakologiskt är steg två i den cellulära signaleringsvägen av störst betydelse och de 
flesta läkemedlen på marknaden idag verkar på receptorns förmåga att översätta 
signalmolekylens meddelande.    
 WNT-signalering är en typ utav cellulär signalering som är mycket viktig vid 
fosterutveckling och vävnadsbalans i vuxna individer. På grund av detta kan felaktig 
WNT-signalering leda till allvarliga sjukdomar, så som cancer och neurodegenerativa 
tillstånd. Steg ett i WNT-signalering utförs av en grupp av 19 närbesläktade proteiner 
som går under namnet WNT. I steg två interagerar WNT främst med en klass av 
receptorer som kallas Frizzled (FZD). Klassen FZD består av 10 proteiner som i steg 
tre interagerar med och för över WNT-meddelandet till två typer av effektorproteiner: 
1) heterotrimera G proteiner – ett vanligt förekommande signalkomplex bestående utav 
tre olika delproteiner (,  och ), och 2) Disheveled (DVL) – ett stort multifunktionellt 
stödstruktursprotein främst knuten till WNT signalering. På grund av likheter i 
strukturellt utseende kategoriseras klassen FZD som G protein kopplade receptorer 
(GPCRs), en proteinfamilj som, vilket namnet antyder, utmärks av deras förmåga att 
kommunicera med heterotrimera G proteiner. Trots deras klassificering finns det en 
debatt kring huruvida FZDs verkligen är sanna GPCR proteiner eftersom biokemiska 
bevis som stödjer en GPCR-hypotes länge har saknas.  
Arbetet i denna avhandling har haft som mål att undersöka kopplingen mellan 
FZD och heterotrimera G proteiner och att föra fram nya bevis som kan understödja 
idén om att FZD fungerar som klassiska GPCRer, som t ex adrenalin- och 
serotoninreceptorer. Resultaten från avhandlingens studier visade att WNT aktiverar G 
proteiner och att FZD6 kan binda G proteiner, men endast vissa subtyper av G 
proteiner. Som nämnts tidigare, utför FZD cellulär signalering genom både G proteiner 
och DVL, ett faktum som är svårtförklarat då receptorns kontaktytor för dessa två 
effektorproteiner nästan helt överlappar varandra. Analys av det molekylära och 
funktionella förhållandet mellan FZD6, DVL och G proteiner visade att kopplingen 
mellan FZD6 och G proteiner, samt WNT-signaleringen genom FZD6, krävde närvaron 
av DVL. Dessa resultat poängterar att klassen FZD har vissa egenskaper som skiljer sig 
från konventionella GPCRer och påvisar förekomsten av en tidigare okänd cellär 
signalöverföringsmekanism. Slutligen har arbetet i denna avhandling identifierat en 
mutation i FZD6 proteinet som ger upphov till en ärftlig nagelsjukdom kallad 
Autosomal recessiv nageldysplasi. Intressant nog visade det sig att muterade FZD6 
proteiner kunde binda till DVL men var oförmögna att koppla till G proteiner.  
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